Abedon, S. T. 2012. Phage therapy best practices, p. ???. In: P. Hyman and S. T. Abedon (eds.), Bacteriophages in Health and Disease. CABI Press, Wallingford, UK. [Publisher] review
Adriaenssens, E. M., V. J. Van, D. Vandenheuvel, V. Dunon, P. J. Ceyssens, P. M. De, A. M. Kropinski, J. P. Noben, M. Maes, and R. Lavigne. 2012. T4-related bacteriophage LIMEstone isolates for the control of soft rot on potato caused by 'Dickeya solani'. PLoS. One. 7:e33227. [Publisher]
Alemayehu, D., P. G. Casey, O. McAuliffe, C. M. Guinane, J. G. Martin, F. Shanahan, A. Coffey, R. P. Ross, and C. Hill. 2012. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio 3:e00029-12 . [Publisher]
Bandara, N., J. Jo, S. Ryu, and K. P. Kim. 2012. Bacteriophages BCP1-1 and BCP8-2 require divalent cations for efficient control of Bacillus cereus in fermented foods. Food Microbiol. 31:9-16. [PubMed] review
Brussow, H. 2012. Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining? MBio. 3: e00061-12. [Publisher]
Briuso<, P. G., <. F. Zubritskii, R. N. Islamo<, A. <. Nizo
Bull, J. J., G. Otto, and I. J. Molineux. 2012. In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model. Antimicrob. Agents Chemother. 56:949-954. [PubMed]
Burrowes, B. and D. R. Harper. 2012. Phage therapy of non-wound infections, p. ???. In: P. Hyman and S. T. Abedon (eds.), Bacteriophages in Health and Disease. CABI Press, Wallingford, UK. [Publisher] review
Chan, B. K. and S. T. Abedon. 2012. Phage therapy pharmacology: phage cocktails. Adv. Appl. Microbiol. 78:1-23. [PubMed] [Local Link] review
Chibeu, A., E. J. Lingohr, L. Masson, A. Manges, J. Harel, H. W. Ackermann, A. M. Kropinski, and P. Boerlin. 2012. Bacteriophages with the ability to degrade uropathogenic Escherichia coli biofilms. Viruses. 4:471-487. [PubMed]
Clark, J., S. T. Abedon, and P. Hyman. 2012?. Phages as therapeutic delivery vehicles, p. ??? (in press). In : P. Hyman and S. T. Abedon (eds.), Bacteriophages in Health and Disease. CABI Press, Wallingford, UK. [Publisher] review
Edgar, R., N. Friedman, S. Molshanski-Mor, and U. Qimron. 2012. Reversing bacterial resistance to antibiotics by phage-mediated delivery of dominant sensitive genes. Appl. Environ. Microbiol. 78:744-751. [PubMed]
Escobar-Páramo, P., C. Gougat-Barbera, and M. E. Hochberg. 2012. Evolutionary dynamics of separate and combined exposure of Pseudomonas fluorescens SBW25 to antibiotics and bacteriophage. Evol.Appl. DOI: 10.1111/j.1752-4571.2012.00248.x. [Publisher]
García, P., B. Martínez, L. Rodríguez, D. Gutiérrez, and A. Rodríguez. 2012. Bacteriophages as biocontrol agents in dairy processing, p. 269-294. In: A. Quiberoni and J. Reinheimer (eds.), Bacteriophages in Dairy Processing. Nova Science Publishers, Hauppauge, New York. [Publisher] review
Guenther, S., O. Herzig, L. Fieseler, J. Klumpp, and M. J. Loessner. 2012. Biocontrol of Salmonella Typhimurium in RTE foods with the virulent bacteriophage FO1-E2. Int. J. Food Microbiol. 154:66-72. [PubMed]
Hall, A. R., V. D. De, V. P. Friman, J. P. Pirnay, and A. Buckling. 2012. Effects of sequential and simultaneous application of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in waxmoth larvae. Appl. Environ. Microbiol. [PubMed]
Haq, I. U., W. N. Chaudhry, M. N. Akhtar, S. Andleeb, and I. Qadri. 2012. Bacteriophages and their implications on future biotechnology: a review. Virol. J 9:9. [PubMed] review
Kelly, D., O. McAuliffe, R. P. Ross, and A. Coffey. 2012. Prevention of Staphylococcus aureus biofilm formation and reduction in established biofilm density using a combination of phage K and modified derivatives. Lett Appl. Microbiol. [PubMed]
Kuchment, A. 2012. The Forgotten Cure: The Past and Future of Phage Therapy. Springer, New York [Google Books]
Loc-Carrillo, C., S. Wu, and J. P. Beck. 2012. Phage therapy of wounds and related purulent infections, p. ???. In: P. Hyman and S. T. Abedon (eds.), Bacteriophages in Health and Disease. CABI Press, Wallingford, UK. [Publisher] review
Niu, Y. D., K. Stanford, T. A. McAllister, and T. R. Callaway. 2012. Role of phages in control of bacterial pathogens in food, p. ???. In: P. Hyman and S. T. Abedon (eds.), Bacteriophages in Health and Disease. CABI Press, Wallingford, UK. [Publisher] review
Olszowaska-Zaremba, N., J. Borysowski, J. Dabrowska, and A. Górski. 2012. Phage translocation, safety, and immunomodulation, p. ???. In: P. Hyman and S. T. Abedon (eds.), Bacteriophages in Health and Disease. CABI Press, Wallingford, UK. [Publisher] review
Pouillot, F., M. Chomton, H. Blois, C. Courroux, J. Noelig, P. Bidet, E. Bingen, and S. Bonacorsi. 2012. Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15. Antimicrob. Agents Chemother. 56:3568-3575. [PubMed]
Praveenya, P., K. S. Brijesh, K. D. Sathish, and K. Purvi. 2012. Antibiotic resistance creating new epoch. J.Bacteriol.Parasitol. 3:131. [Publisher] review
Ryan, E. M., M. Y. Alkawareek, R. F. Donnelly, and B. F. Gilmore. 2012. Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. FEMS Immunol. Med. Microbiol. 65:395-398. [PubMed]
Sharma, M., and G. V. Sharma. 2012. Bacteriophages, pp. 285-296?. In: V. M. Gómez-López (ed.), Decontamination of Fresh and Minimally Processed Produce. Wiley-Blackwell, Oxford, UK. [Publisher] [Google Books] review
Thawal, N. D., A. B. Yele, P. K. Sahu, and B. A. Chopade. 2012. Effect of a novel podophage AB7-IBB2 on Acinetobacter baumannii biofilm. Curr. Microbiol. 65:66-72. [PubMed]
Abedon, S. 2011. Phage therapy pharmacology: calculating phage dosing. Adv. Appl. Microbiol. 77:1-40. [PubMed] [Local Link] review
Abedon, S. T. 2011. Bacteriophages and Biofilms: Ecology, Phage Therapy, Plaques. Nova Science Publishers, Hauppauge, New York. [Publisher] [Google Books] [Local Link] review
Abedon, S. T., S. J. Kuhl, B. G. Blasdel, and E. M. Kutter. 2011. Phage treatment of human infections. Bacteriophage 1:66-85. [PubMed] [Local Link] review
Ahiwale, S., N. Tamboli, K. Thorat, R. Kulkarni, H. Ackermann, and B. Kapadnis. 2011. In vitro management of hospital Pseudomonas aeruginosa biofilm using indigenous T7-like lytic phage. Curr. Microbiol. 62:335-340. [PubMed]
Alam, M., M. Z. Akhter, M. Yasmin, C. R. Ahsan, and J. Nessa. 2011. Local bacteriophage isolates showed anti- Escherichia coli O157:H7 potency in an experimental ligated rabbit ileal loop model. Can. J. Microbiol. 57:408-415. [PubMed]
Alfadhel, M., U. Puapermpoonsiri, S. J. Ford, F. J. McInnes, and C. F. van der Walle. 2011. Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: in vitro evaluation. Int. J Pharm. 416:280-287. [PubMed]
Anany, H., W. Chen, R. Pelton, and M. W. Griffiths. 2011. Biocontrol of Listeria monocytogenes and Escherichia coli O157:H7 in meat by using phages immobilized on modified cellulose membranes. Appl. Environ. Microbiol. 77:6379-6387. [PubMed]
Burrowes, B., D. R. Harper, J. Anderson, M. McConville, and M. C. Enright. 2011. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Rev Anti. Infect. Ther. 9:775-785. [PubMed] review
Callaway, T. R., T. S. Edrington, R. C. Anderson, J. A. Byrd, M. H. Kogut, R. B. Harvey, and D. J. Nisbet. 2011. Using antimicrobial cultures, bacteriocins and bacteriophages to reduce carriage of food-borne pathogens in cattle and swine, p. ???. In: C. Lacroix (ed.), Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Woodhead Publishing, Cambridge, UK. review
Castillo-Ruiz, M., E. D. Vines, C. Montt, J. Fernandez, J. M. Delgado, J. C. Hormazabal, and M. Bittner. 2011. Isolation of a novel Aggregatibacter actinomycetemcomitans serotype b bacteriophage capable of lysing bacteria within a biofilm. Appl. Environ. Microbiol. 77:3157-3159. [PubMed]
Choi, J., S. M. Kotay, and R. Goel. 2011. Bacteriophage-based biocontrol of biological sludge bulking in wastewater. Bioeng. Bugs. 2:214-217. [PubMed]
Coffey, B., L. Rivas, G. Duffy, A. Coffey, R. P. Ross, and O. McAuliffe. 2011. Assessment of Escherichia coli O157:H7-specific bacteriophages e11/2 and e4/1c in model broth and hide environments. Int. J. Food Microbiol. 147:188-194. [PubMed]
Connerton, P. L., A. R. Timms, and I. F. Connerton. 2011. Campylobacter bacteriophages and bacteriophage therapy. J. Appl. Microbiol. 111:255-265. [PubMed]
Connerton, P. L., A. R. Timms, and I. F. Connerton. 2011. Using antimicrobial cultures, bacteriocins and bacteriophages to reduce carriage of foodborne bacterial pathogens in poultry, p. ???. In: C. Lacroix (ed.), Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Woodhead Publishing, Cambridge, UK. [PubMed] review
Cornelissen, A., P. J. Ceyssens, J. T'Syen, P. H. Van, J. P. Noben, O. V. Shaburova, V. N. Krylov, G. Volckaert, and R. Lavigne. 2011. The T7-related Pseudomonas putida phage phi15 displays virion-associated biofilm degradation properties. PLoS. One. 6:e18597.
Curtright, A. J. and S. T. Abedon. 2011. Phage therapy: emergent property pharmacology. J. Bioanal. Biomed. S6:002. [Publisher] [Local Link] review
Deasy, T., J. Mahony, H. Neve, K. J. Heller, and D. van Sinderen. 2011. Isolation of a virulent Lactobacillus brevis phage and its application in the control of beer spoilage. J Food Prot. 74:2157-2161. [PubMed]
Fazil, M. H. and D. V. Singh. 2011. Vibrio cholerae infection, novel drug targets and phage therapy. Future. Microbiol. 6:1199-1208. [PubMed] review
Fieseler, L. and M. J. Loessner. 2011. Bacteriophages and food safety, p. ???. In: C. Lacroix (ed.), Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Woodhead Publishing, Cambridge, UK. review
Fujiwara, A., M. Fujisawa, R. Hamasaki, T. Kawasaki, M. Fujie, and T. Yamada. 2011. Biocontrol of Ralstonia solanacearum by treatment with lytic bacteriophages. Appl. Environ. Microbiol. [PubMed]
Gill, J. J. and R. Young. 2011. Therapeutic applications of phage biology: history, practice and recommendations, p. ???. In: A. A. Miller and P. F. Miller (eds.), Emerging Trends in Antibacterial Discovery: Answering the Call to Arms. Caister Academic Press, Norfolk,UK. [Publisher] review
Goodridge, L. D. and B. Bisha. 2011. Phage-based biocontrol strategies to reduce foodborne pathogens in foods. Bacteriophage 1:130-137. [PubMed] review
Guenther, S. and M. J. Loessner. 2011. Bacteriophage biocontrol of Listeria monocytogenes on soft ripened white mold and red-smear cheeses. Bacteriophage 1:94-100. [PubMed]
Harper, D. R. and M. C. Enright. 2011. Bacteriophages for the treatment of Pseudomonas aeruginosa infections. J Appl. Microbiol. 111:1-7. [PubMed] review
Hooton, S. P., R. J. Atterbury, and I. F. Connerton. 2011. Application of a bacteriophage cocktail to reduce Salmonella Typhimurium U288 contamination on pig chicken skin. Int. J. Food Microbiol. 151:157-163. [PubMed]
Hung, C. H., C. F. Kuo, C. H. Wang, C. M. Wu, and N. Tsao. 2011. Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice. Antimicrob. Agents Chemother. 55:1358-1365. [PubMed]
Kelly, D., O. McAuliffe, R. P. Ross, J. O'Mahony, and A. Coffey. 2011. Development of a broad-host-range phage cocktail for biocontrol. Bioeng. Bugs. 2:31-37. [PubMed]
Khawaldeh, A., S. Morales, B. Dillon, Z. Alavidze, A. N. Ginn, L. Thomas, S. J. Chapman, A. Dublanchet, A. Smithyman, and J. R. Iredell. 2011. Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection. J Med. Microbiol. 60:1697-1700. [PubMed]
Knezevic, P., D. Obreht, S. Curcin, M. Petrusic, V. Aleksic, R. Kostanjsek, and O. Petrovic. 2011. Phages of Pseudomonas aeruginosa: response to environmental factors and in vitro ability to inhibit bacterial growth and biofilm formation. J. Appl. Microbiol. 111:245-254. [PubMed]
Kotay, S. M., T. Datta, J. Choi, and R. Goel. 2011. Biocontrol of biomass bulking caused by Haliscomenobacter hydrossis using a newly isolated lytic bacteriophage. Water Res 45:694-704. [PubMed]
Kumari, S., K. Harjai, and S. Chhibber. 2011. Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. J Med. Microbiol. 60:205-210. [PubMed]
Kvachadze, L., N. Balarjishvili, T. Meskhi, E. Tevdoradze, N. Skhirtladze, T. Pataridze, R. Adamia, T. Topuria, E. Kutter, C. Rohde, and M. Kutateladze. 2011. Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens. Microb. Biotechnol. ??? [PubMed]
Lim, T. H., D. H. Lee, Y. N. Lee, J. K. Park, H. N. Youn, M. S. Kim, H. J. Lee, S. Y. Yang, Y. W. Cho, J. B. Lee, S. Y. Park, I. S. Choi, and C. S. Song. 2011. Efficacy of bacteriophage therapy on horizontal transmission of Salmonella gallinarum on commercial layer chickens. Avian Dis. 55:435-438. [PubMed]
Loc-Carrillo, C. and S. T. Abedon. 2011. Pros and cons of phage therapy. Bacteriophage 1:111-114. [PubMed] [Local Link] review
Lu, T. K. and M. S. Koeris. 2011. The next generation of bacteriophage therapy. Curr Opin Microbiol. 14:524-531. review
Mahony, J., O. McAuliffe, R. P. Ross, and S. D. van. 2011. Bacteriophages as biocontrol agents of food pathogens. Curr Opin Biotechnol. 22:157-163. [PubMed] review
Maura, D., E. Morello, M. L. du, P. Bomme, B. C. Le, and L. Debarbieux. 2011. Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice. Environ. Microbiol. ??? [PubMed]
Medina, M. and M. Nuñez. 2011. Applications of protective cultures, bacteriocins and bacteriophages in milk and dairy products, p. ???. In: C. Lacroix (ed.), Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Woodhead Publishing, Cambridge, UK. review
Moradpour, Z. and A. Ghasemian. 2011. Modified phages: Novel antimicrobial agents to combat infectious diseases. Biotechnol. Adv. 29:732-738 [PubMed]. review
Morello, E., E. Saussereau, D. Maura, M. Huerre, L. Touqui, and L. Debarbieux. 2011. Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS One 6:e16963. [PubMed]
Paul, V. D., S. Sundarrajan, S. S. Rajagopalan, S. Hariharan, N. Kempashanaiah, S. Padmanabhan, B. Sriram, and J. Ramachandran. 2011. Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection. BMC Microbiol. 11:195. [PubMed]
Pilet, M.-F. and F. Leroi. 2011. Applications of protective cultures, bacteriocins and bacteriophages in fresh seafood and seafood products, p. ???. In: C. Lacroix (ed.), Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Woodhead Publishing, Cambridge, UK. review
Pires, D., S. Sillankorva, A. Faustino, and J. Azeredo. 2011. Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilm. Res. Microbiol. 162:798-806. [PubMed]
Pirnay, J. P., V. D. De, G. Verbeken, M. Merabishvili, N. Chanishvili, M. Vaneechoutte, M. Zizi, G. Laire, R. Lavigne, I. Huys, G. Van den Mooter, A. Buckling, L. Debarbieux, F. Pouillot, J. Azeredo, E. Kutter, A. Dublanchet, A. Górski, and R. Adamia. 2011. The phage therapy paradigm: prêt-à-porter or sur-mesure? ["Ready-to-wear or custom-made"] Pharm. Res. 28:934-937. [PubMed] review
Raya, R. R., R. A. Oot, B. Moore-Maley, S. Wieland, T. R. Callaway, E. Kutter, and A. D. Brabban. 2011. Naturally resident and exogenously applied T4-like and T5-like bacteriophages can reduce Escherichia coli O157:H7 levels in sheep guts. Bacteriophage 1. [PubMed]
Ryan, E. M., S. P. Gorman, R. F. Donnelly, and B. F. Gilmore. 2011. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. J. Pharm. Pharmacol. 63:1253-1264. [PubMed] review
Siringan, P., P. L. Connerton, R. J. Payne, and I. F. Connerton. 2011. Bacteriophage-mediated dispersal of Campylobacter jejuni biofilms. Appl. Environ. Microbiol. 77:3320-3326. [PubMed]
Tiwari, B. R., S. Kim, M. Rahman, and J. Kim. 2011. Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models. J Microbiol. 49:994-999. [PubMed]
Tothova, L., P. Celec, J. Babickova, J. Gajdosova, H. Al-Alami, N. Kamodyova, H. Drahovska, A. Liptakova, J. Turna, and J. Hodosy. 2011. Phage therapy of Cronobacter-induced urinary tract infection in mice. Med. Sci. Monit. 17:BR173-BR178. [PubMed]
Volkel, I. and C. P. Czerny. 2011. [Phage therapy in the fields of veterinary medicine: an overview]. Berl Munch. Tierarztl. Wochenschr. 124:303-312. [PubMed] review
Abedon, S. T. 2010. Bacteriophages and biofilms, p. 1-58. In: W. C. Bailey (ed.), Biofilms: Formation, Development and Properties. Nova Science Publishers, Hauppauge, New York. [Publisher] review
Abedon, S. T. 2010. The 'nuts and bolts' of phage therapy. Curr. Pharm. Biotechnol. 11:1. [Publisher]
Abedon, S. T. and C. Thomas-Abedon. 2010. Phage therapy pharmacology. Curr. Pharm. Biotechnol. 11:28-47. [PubMed] (click on link to publisher page, i.e., Bentham Direct, then click "View", and then click on "Full Text"; finally, click on "Download") review
Balogh, B., J. B. Jones, F. B. Iriarte, and M. T. Momol. 2010. Phage therapy for plant disease control. Curr. Pharm. Biotechnol. 11:48-57. [PubMed] (click on link to publisher page, i.e., Bentham Direct, then click "View", and then click on "Full Text"; finally, click on "Download") review
Boerlin, P. 2010. Implications of antimicrobial agents as therapeutics and growth promoters in food animal production, p. 1-9. In: P. M. Sabour and M. W. Griffiths (eds.), Bacteriophages in the Control of Food- and Waterborne Pathogens. ASM Press, Washington, DC. [Publisher] review
Brüssow, H. 2010. Control of bacterial diarrhea with phages: coverage and safety issues in bacteriophage therapy, p. 273-295. In: P. M. Sabour and M. W. Griffiths (eds.), Bacteriophages in the Control of Food- and Waterborne Pathogens. ASM Press, Washington, DC. [Publisher] review
Budynek, P., K. Dabrowska, G. Skaradzinski, and A. Górski. 2010. Bacteriophages and cancer. Arch. Microbiol. 192:315-320. [Publisher] review
Bull, J. J., E. R. Vimr, and I. J. Molineux. 2010. A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli. Virology 398:79-86. [Publisher]
Capparelli, R., N. Nocerino, M. Iannaccone, D. Ercolini, M. Parlato, M. Chiara, and D. Iannelli. 2010. Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy. J. Infect. Dis. 201:52-61. [Publisher]
Carmody, L. A., J. J. Gill, E. J. Summer, U. S. Sajjan, C. F. Gonzalez, R. F. Young, and J. J. LiPuma. 2010. Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection. J Infect. Dis. 201:264-271. [Publisher]
Carvalho, C. M., B. W. Gannon, D. E. Halfhide, S. B. Santos, C. M. Hayes, J. M. Roe, and J. Azeredo. 2010. The In vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens. BMC. Microbiol. 10:232. [Publisher]
Coffey, B., S. Mills, A. Coffey, O. McAuliffe, and R. P. Ross. 2010. Phage and their lysins as biocontrol agents for food safety applications. Annu. Rev. Food Sci. Technol. 1:449-468. [Publisher] review
Connerton, P. L., A. R. Timms, and I. F. Connerton. 2010. Using antimicrobial cultures, bacteriocins and bacteriophages to reduce carriage of foodborne bacterial pathogens in poultry, p. ???. In: C. Lacroix (ed.), Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Woodhead Publishing and CRC Press, Boca Raton, FL. [Publisher] review
Debarbieux, L., D. Leduc, D. Maura, E. Morello, A. Criscuolo, O. Grossi, V. Balloy, and L. Touqui. 2010. Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections. J. Infect. Dis. 201 :1096-1104. [Publisher]
Fu, W., T. Forster, O. Mayer, J. J. Curtin, S. M. Lehman, and R. M. Donlan. 2010. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob. Agents Chemother. 54:397-404. [PubMed]
Garbe, J., A. Wesche, B. Bunk, M. Kazmierczak, K. Selezska, C. Rohde, J. Sikorski, M. Rohde, D. Jahn, and M. Schobert. 2010. Characterization of JG024, a Pseudomonas aeruginosa PB1-like broad-host range phage under simulated infection conditions. BMC. Microbiol. 10:301. [PubMed]
Ghaemi, A., H. Soleimanjahi, P. Gill, Z. Hassan, S. R. Jahromi, and F. Roohvand. 2010. Recombinant lambda-phage nanobioparticles for tumor therapy in mice models. Genet. Vaccines. Ther. 8:3. [PubMed]
Gill, J. J. and P. Hyman. 2010. Phage choice, isolation and preparation for phage therapy. Curr. Pharm. Biotechnol. 11:2-14. [PubMed] (click on link to publisher page, i.e., Bentham Direct, then click "View", and then click on "Full Text"; finally, click on "Download") review
Gill, J. J. 2010. Practical and theoretical considerations for the use of bacteriophages in food systems, p. 217-235. In: P. M. Sabour and M. W. Griffiths (eds.), Bacteriophages in the Control of Food- and Waterborne Pathogens. ASM Press, Washington, DC. [Publisher] review
Gino, E., J. Starosvetsky, E. Kurzbaum, and R. Armon. 2010. Combined chemical-biological treatment for prevention/rehabilitation of clogged wells by an iron-oxidizing bacterium. Environ. Sci. Technol.44:3123-3129. [Publisher]
Golshahi, L., K. H. Lynch, J. J. Dennis, and W. H. Finlay. 2010. In vitro lung delivery of bacteriophages KS4-M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis. J. Appl. Microbiol.110:106-117. [Publisher]
Golshahi, L., K. D. Seed, J. J. Dennis, and W. H. Finlay. 2010. Toward modern inhalational bacteriophage therapy: nebulization of bacteriophages of Burkholderia cepacia complex. J. Aerosol Med. Pulm. Drug Deliv. 21:351-360. [Publisher]
Goodridge, L. D. 2010. Designing phage therapeutics. Curr. Pharm. Biotechnol. 11:15-27. [PubMed] (click on link to publisher page, i.e., Bentham Direct, then click "View", and then click on "Full Text"; finally, click on "Download") review
Goodridge, L. D. 2010. Application of bacteriophages to control pathogens in food animal production, p. 61-77. In: P. M. Sabour and M. W. Griffiths (eds.), Bacteriophages in the Control of Food- and Waterborne Pathogens. ASM Press, Washington, DC. [Publisher] review
Gvasalia, G., E. Kutter, Z. Alavidze, and T. Danelia. 2010. Phage therapy of surgical infections. Experimental and Clinical Medicine (Tbilisi, Georgia) 2:9-14. review
Hagens, S. and M. J. Loessner. 2010. Bacteriophage for biocontrol of foodborne pathogens: calculations and considerations. Curr. Pharm. Biotechnol. 11:58-68. [PubMed] (click on link to publisher page, i.e., Bentham Direct, then click "View", and then click on "Full Text"; finally, click on "Download") review
Hawkins, C., D. Harper, D. Burch, E. Anggard, and J. Soothill. 2010. Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: A before/after clinical trial. Vet. Microbiol. 145:309-313. [PubMed]
Hudson, J. A., L. McIntyre, and C. Billington. 2010. Application of bacteriophages to control pathogenic and spoilage bacteria in food processing and distribution, p. 119-135. In: P. M. Sabour and M. W. Griffiths (eds.), Bacteriophages in the Control of Food- and Waterborne Pathogens. ASM Press, Washington, DC. [Publisher] review
Hudson, J. A., T. Bigwood, A. Premaratne, C. Billington, B. Horn, and L. McIntyre. 2010. Potential to use ultraviolet-treated bacteriophages to control foodborne pathogens. Foodborne. Pathog. Dis. 7:687-693. [PubMed]
Huff, W. E., G. R. Huff, N. C. Rath, and A. M. Donoghue. 2010. Immune interference of bacteriophage efficacy when treating colibacillosis in poultry. Poult. Sci. 89:895-900. [Publisher]
Klieve, A. 2010. Reducing emissions from livestock research program: Archaeaphage therapy to control rumen methanogens. Ref Type: Report [This is not a phage therapy reference but instead a microbe-mediated biocontrol of microorganisms reference]
Kumari, S., K. Harjai, and S. Chhibber. 2010. Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice. J Microbiol. Biotechnol. 20:935-941. [PubMed]
Kutateladze, M. and R. Adamia. 2010. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 28:591-595. [PubMed] review
Kutter, E., D. De Vos, G. Gvasalia, Z. Alavidze, L. Gogokhia, S. Kuhl, and S. T. Abedon. 2010. Phage therapy in clinical practice: treatment of human infections. Curr. Pharm. Biotechnol. 11:69-86. [PubMed] (click on link to publisher page, i.e., Bentham Direct, then click "View", and then click on "Full Text"; finally, click on "Download") review
Lacroix, C. 2010. protective cultures, antimicrobial metabolites and bacteriophages for food and beverage biopreservation, p. ???. In ???. CRC Press, Boca Raton, FL. review
Letarov, A. V., A. K. Golomidova, and K. K. Tarasyan. 2010. Ecological basis of rational phage therapy. Acta Naturae 2:60-71. [Publisher] review
Letkiewicz, S., R. Miedzybrodzki, M. Klak, E. Jonczyk, B. Weber-Dabrowska, and A. Górski. 2010. The perspectives of the application of phage therapy in chronic bacterial prostatitis. FEMS Immunol Med. Microbiol. 60:99-112. [PubMed] review
Meader, E., M. J. Mayer, M. J. Gasson, D. Steverding, S. R. Carding, and A. Narbad. 2010. Bacteriophage treatment significantly reduces viable Clostridium difficile and prevents toxin production in an in vitro model system. Anaerobe 16:549-554. [PubMed]
Miller, R. W., E. J. Skinner, A. Sulakvelidze, G. F. Mathis, and C. L. Hofacre. 2010. Bacteriophage therapy for control of necrotic enteritis of broiler chickens experimentally infected with Clostridium perfringens. Avian Dis. 54:33-40. [Publisher]
Monk, A. B., C. D. Rees, P. Barrow, S. Hagens, and D. R. Harper. 2010. Bacteriophage applications: where are we now? Lett Appl. Microbiol. 51:363-369. [Publisher] review
Moussa, Z. 2010. Biological Control of Brown Rot Disease of Potato: by using Bacteriophage, Actinomycetes, Essential Oil, Basidiomycetes. VDM Verlag. review
Nakai, T. 2010. Application of bacteriophages for control of infectious diseases in aquaculture, p. 257-272. In: P. M. Sabour and M. W. Griffiths (eds.), Bacteriophages in the Control of Food- and Waterborne Pathogens. ASM Press, Washington, DC. [Publisher] review
Obeso, J. M., P. Garcia, B. Martinez, F. N. Arroyo-Lopez, A. Garrido-Fernandez, and A. Rodriguez. 2010. Use of logistic regression for predicting Staphylococcus aureus fate in pasteurized milk in the presence of two lytic phages. Appl. Environ. Microbiol. 76:6038-6046. [Publisher]
Oliveira, A., R. Sereno, and J. Azeredo. 2010. In vivo efficiency evaluation of a phage cocktail in controlling severe colibacillosis in confined conditions and experimental poultry houses. Vet. Microbiol. 146:303-308. [PubMed]
Pouillot, F., H. Blois, and F. Iris. 2010. Genetically engineered virulent phage banks in the detection and control of emergent pathogenic bacteria. Biosecur. Bioterror. 8:155-169. [Publisher]
Sillankorva, S., P. Neubauer, and J. Azeredo. 2010. Phage control of dual species biofilms of Pseudomonas fluorescens and Staphylococcus lentus. Biofouling 26:567-575. [Publisher]
Son, J. S., S. J. Lee, S. Y. Jun, S. J. Yoon, S. H. Kang, H. R. Paik, J. O. Kang, and Y. J. Choi. 2010. Antibacterial and biofilm removal activity of a Podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme. Appl. Microbiol. Biotechnol. 86:1439-1449. [PubMed]
Soni, K. A. and R. Nannapaneni. 2010. Removal of monocytogenes biofilms with bacteriophage P100. J. Food Prot. 73:1519-1524. [PubMed]
Stanford, K., T. A. McAllister, Y. D. Niu, T. P. Stephens, A. Mazzocco, T. E. Waddell, and R. P. Johnson. 2010. Oral delivery systems for encapsulated bacteriophages targeted at Escherichia coli O157:H7 in feedlot cattle. J. Food Prot. 73:1304-1312. [PubMed]
Sulakvelidze, A. and G. R. Pasternack. 2010. Industrial and regulatory issues in bacteriophage applications in food production and processing, p. 297-326. In: P. M. Sabour and M. W. Griffiths (eds.), Bacteriophages in the Control of Food- and Waterborne Pathogens. ASM Press, Washington, DC. [PubMed] review
Sunagar, R., S. A. Patil, and R. K. Chandrakanth. 2010. Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice. Res. Microbiol. 161:854-860. [PubMed]
Svircev, A. M., A. J. Castle, and S. M. Lehman. 2010. Bacteriophages for control of phytopathogens in food production systems, p. 79-102. In: P. M. Sabour and M. W. Griffiths (eds.), Bacteriophages in the Control of Food- and Waterborne Pathogens. ASM Press, Washington, DC. [Publisher] review
Then, R. L. and H. G. Sahl. 2010. Anti-infective strategies of the future: is there room for species-specific antibacterial agents? Curr. Pharm. Des. 16:555-566. [PubMed] [Local Link] review
Wall, S. K., J. Zhang, M. H. Rostagno, and P. D. Ebner. 2010. Phage therapy to reduce preprocessing Salmonella infections in market-weight swine. Appl. Environ. Microbiol. 76:48-53. [Publisher]
Wang, Q. and P. M. Sabour. 2010. Encapsulation and controlled release of bacteriophages for food animal production, p. 237-255. In: P. M. Sabour and M. W. Griffiths (eds.), Bacteriophages in the Control of Food- and Waterborne Pathogens. ASM Press, Washington, DC. [Publisher] review
Ye, J., M. Kostrzynska, K. Dunfield, and K. Warriner. 2010. Control of Salmonella on sprouting mung bean and alfalfa seeds by using a biocontrol preparation based on antagonistic bacteria and lytic bacteriophages. J. Food Prot. 73:9-17. [PubMed]
Zimecki, M., J. Artym, M. Kocieba, B. Weber-Dabrowska, J. Borysowski, and A. Górski. 2010. Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus. Med. Microbiol. Immunol 199:71-79. [PubMed]
??? 2009. Animal studies, p. ???. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
??? 2009. Experience of prophylactic "phaging " or phage prophylaxis, p. ???. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
??? 2009. Phage therapy in gynocology, p. ???. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
??? 2009. Phage therapy in surgery and wound treatment, p. ???. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
??? 2009. Phages potentially applicable against bioterrorism, p. ???. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
??? 2009. Use of phage treatment for plant protection, p. ???. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
Abedon, S. T. 2009. Kinetics of phage-mediated biocontrol of bacteria. Foodborne Pathog. Dis. 6:807-815. review
Abedon, S. T. 2009. Impact of phage properties on bacterial survival, p. 217-235. In: H. T. Adams (ed.), Contemporary Trends in Bacteriophage Research. Nova Science Publishers, Hauppauge, New York. [Publisher] [Google Books] [Local Link] review
Almeida, A., A. Cunha, N. C. M. Gomes, E. Alves, L. Costa, and M. A. F. Faustino. 2009. Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants. Marine Drugs 7:268-313. review
Atterbury, R. J. 2009. Bacteriophage biocontrol in animals and meat products. Microb. Biotechnol. 2:601-612. review
Bhowmick, T. S., H. Koley, M. Das, D. R. Saha, and B. L. Sarkar. 2009. Pathogenic potential of vibriophages against an experimental infection with Vibrio cholerae O1 in the RITARD model. Int. J. Antimicrob. Agents 33:569-573.
Bigwood, T., J. A. Hudson, and C. Billington. 2009. Influence of host and bacteriophage concentrations on the inactivation of food-borne pathogenic bacteria by two phages. FEMS Microbiol. Lett. 291:59-64.
Borie, C., M. L. Sanchez, C. Navarro, S. Ramirez, M. A. Morales, J. Retamales, and J. Robeson. 2009. Aerosol spray treatment with bacteriophages and competitive exclusion reduces Salmonella enteritidis infection in chickens. Avian Dis. 53:250-254.
Brüssow, H. 2009. Bacteriophage – therapy, p. ???. In: Encyclopedia of Microbiology. review
Cairns, B. J., A. R. Rimms, V. A. A. Jansen, I. F. Connerton, and R. J. H. Payne. 2009. Quantitative models of in vitro bacteriophage-host dynamics and their application to phage therapy. PLoS Path. 5:e1000253.
Chanishvili, N. and R. Sharp. 2009. A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
Chanishvili, N. 2009. Combined phage- and sero- therapy. (vaccination). development of phage-vaccines, p. 68-73. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
Chanishvili, N., N. Khurtsia, and I. Malkhazova. 2009. Combined use of phages and antibiotics, p. 74-81. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
Chanishvili, N., M. Goderdzishvili, and T. Chanishvili. 2009. Methodology for manufacturing of bacteriophages in industrial scale, p. 173-??? In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
Chanishvili, N., I. Malkhazova, and N. Khurtsia. 2009. Phage therapy against intestinal infections, p. 33-58. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
Chanishvili, N., I. Malkhazova, and N. Khurtsia. 2009. Phage therapy in dermatology, p. 16-20. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
Chanishvili, N. and N. Karanadze. 2009. Phage therapy in opthalmology, p. 63-67. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
Chanishvili, N. 2009. Phage therapy in urology, p. 59-60. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
Chanishvili, T. 2009. Phage therapy against septic infections, p. 113-128. In: N. Chanishvili and R. Sharp (eds.), A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute, Tbilisi, Georgia. review
Courchesne, N. M., A. Parisien, and C. Q. Lan. 2009. Production and application of bacteriophage and bacteriophage-encoded lysins. Recent Patents On Biotechnology 3:37-45. review
Denou, E., A. Bruttin, C. Barretto, C. Ngom-Bru, H. Brüssow, and S. Zuber. 2009. T4 phages against Escherichia coli diarrhea: potential and problems. Virology 388:21-30.
Deresinski, S. 2009. Bacteriophage therapy: exploiting smaller fleas. Clin. Infect. Dis. 48:1096-1101. review
Donlan, R. M. 2009. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol. 17:66-72. review
el-Shibiny, A., A. Scott, A. Timms, Y. Metawea, P. Connerton, and I. Connerton. 2009. Application of a group II Campylobacter bacteriophage to reduce strains of Campylobacter jejuni and Campylobacter coli colonizing broiler chickens. J Food Prot. 72:733-740.
Goldman, G., J. Starosvetsky, and R. Armon. 2009. Inhibition of biofilm formation on UF membrane by use of specific bacteriophages. J. Membr. Sci. 342:145-152.
Górski, A., M. Targonska, J. Borysowski, and B. Weber-Dabrowska. 2009. The potential of phage therapy in bacterial infections of the eye. Ophthalmologica 223:162-165. review
Górski, A., R. Miedzybrodzki, J. Borysowski, B. Weber-Dabrowska, M. Lobocka, W. Fortuna, S. Letkiewicz, M. Zimecki, and G. Filby. 2009. Bacteriophage therapy for the treatment of infections. Curr. Opin. Investig. Drugs 10:766-774. review
Guenther, S., D. Huwyler, S. Richard, and M. J. Loessner. 2009. Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods. Appl. Environ. Microbiol. 75:93-100.
Harper, D. R. and E. Kutter. 2009. Bacteriophage: therapeutic use, p. 1-7. In: Encyclopedia of Life Sciences. John Wiley & Sons, Ltd. review
Heo, Y. J., Y. R. Lee, H. H. Jung, J. Lee, G. Ko, and Y. H. Cho. 2009. Antibacterial efficacy of phages against Pseudomonas aeruginosa infections in mice and Drosophila melanogaster. Antimicrob. Agents Chemother. 53:2469-2474.
Housby, J. N. and N. H. Mann. 2009. Phage therapy. Drug Discov. Today 14:536-540. review
Jamalludeen, N., R. P. Johnson, P. E. Shewen, and C. L. Gyles. 2009. Evaluation of bacteriophages for prevention and treatment of diarrhea due to experimental enterotoxigenic Escherichia coli O149 infection of pigs. Vet. Microbiol. 136:135-141.
Kallings, L. O. 2009. [Bacteriophage therapy revisited]. Lakartidningen 106:2708. review
Klein, G. O. 2009. [Bacteriophage therapy can be the rescue when antibiotics no longer work]. Lakartidningen 106:2530-2533. review
Kocharunchitt, C., T. Ross, and D. L. McNeil. 2009. Use of bacteriophages as biocontrol agents to control Salmonella associated with seed sprouts. Int. J. Food Microbiol. 128:453-459.
Kumari, S., K. Harjai, and S. Chhibber. 2009. Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae. J Microbiol Biotechnol 19:622-628.
Kurzepa, A., K. Dabrowska, G. Skaradzinski, and A. Górski. 2009. Bacteriophage interactions with phagocytes and their potential significance in experimental therapy. Clin. Exp Med. 9:93-100.
Kutter, E. M. 2009. Bacteriophage therapy: past and present, p. 258-266. In: M. Schaecter (ed.), Encyclopedia of Microbiology. Elsevier, Oxford. review
Letkiewicz, S., R. Miedzybrodzki, W. Fortuna, B. Weber-Dabrowska, and A. Górski. 2009. Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis—case report. Folia Microbiol. (Praha) 54:457-461.
Lu, T. K. and J. J. Collins. 2009. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc. Natl. Acad. Sci. USA 106:4629-4634.
Merabishvili, M., J.-P. Pirnay, G. Verbeken, N. Chanishvili, M. Tediashvili, N. Lashkhi, T. Glonti, V. Krylov, J. Mast, L. Van Parys, R. Lavigne, G. Volckaert, W. Mattheus, G. Verween, P. De Corte, T. Rose, S. Jennes, M. Zizi, D. De Vos, and M. Vaneechoutte. 2009. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One 4:e4944. review
Miedzybrodzki, R., W. Fortuna, B. Weber-Dabrowska, and A. Górski. 2009. A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin. Exp. Med. 9:303-312.
O'Flaherty, S., R. P. Ross, and A. Coffey. 2009. Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol. Rev. 33:801-819. review
Rhoads, D. D., R. D. Wolcott, M. A. Kuskowski, B. M. Wolcott, L. S. Ward, and A. Sulakvelidze. 2009. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J. Wound Care 18:237-244.
Rozema, E. A., T. P. Stephens, S. J. Bach, E. K. Okine, R. P. Johnson, K. Stanford, and T. A. McAllister. 2009. Oral and rectal administration of bacteriophages for control of Escherichia coli O157:H7 in feedlot cattle. J. Food Prot. 72:241-250.
Seed, K. D. and J. J. Dennis. 2009. Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex. Antimicrob. Agents Chemother. 53:2205-2208.
Teplitski, M. and K. Ritchie. 2009. How feasible is the biological control of coral diseases? Trends Ecol Evol 24:378-385. review
Timms, A., P. Connerton, and I. Connerton. 2009. Bacteriophage intervention to reduce Campylobacter contamination in poultry, p. 121-145. In: P. C. Garnsworthy and J. Wiseman (eds.), Recent Advances in Animal Nutrition. Nottingham University Press, Nottingham, UK.
Uchiyama, J., Y. Maeda, I. Takemura, R. Chess-Williams, H. Wakiguchi, and S. Matsuzaki. 2009. Blood kinetics of four intraperitoneally administered therapeutic candidate bacteriophages in healthy and neutropenic mice. Microbiol. Immunol. 53:301-304.
Weiss, M., E. Denou, A. Bruttin, R. Serra-Moreno, M. L. Dillmann, and H. Brüssow. 2009. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli. Virology 393:16-23.
Wright, A., C. H. Hawkins, E. E. Anggård, and D. R. Harper. 2009. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin. Otolaryng. 34:349-357.
Ye, J., M. Kostrzynska, K. Dunfield, and K. Warriner. 2009. Evaluation of a biocontrol preparation consisting of Enterobacter asburiae JX1 and a lytic bacteriophage cocktail to suppress the growth of Salmonella Javiana associated with tomatoes. J. Food Prot. 72:2284-2292.
Zimecki, M., J. Artym, M. Kocieba, B. Weber-Dabrowska, J. Borysowski, and A. Górski. 2009. Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus. BMC Microbiol. 9:169.
Abuladze, T., M. Li, M. Y. Menetrez, T. Dean, A. Senecal, and A. Sulakvelidze. 2008. Bacteriophages reduce experimental contamination of hard surfaces, tomato, spinach, broccoli, and ground beef by Escherichia coli O157:H7. Appl. Environ. Microbiol. 74:6230-6238.
Azeredo, J. and I. W. Sutherland. 2008. The use of phages for the removal of infectious biofilms. Curr. Pharm. Biotechnol. 9:261-266. review
Balogh, B., B. I. Canteros, R. E. Stall, and J. B. Jones. 2008. Control of citrus canker and citrus bacterial spot with bacteriophages. Plant Dis. 92:1048-1052.
Bar, H., I. Yacoby, and I. Benhar. 2008. Killing cancer cells by targeted drug-carrying phage nanomedicines. BMC Biotechnol. 8:37.
Barrow, P. and I. Connerton. 2008. Bacteriophages and control of animal diseases. Culture 29:5-8. review
Bigwood, T., J. A. Hudson, C. Billington, G. V. Carey-Smith, and J. A. Heinemann. 2008. Phage inactivation of foodborne pathogens on cooked and raw meat. Food Microbiol. 25:400-406.
Borie, C., I. Albala, P. Sànchez, M. L. Sánchez, S. Ramírez, C. Navarro, M. A. Morales, A. J. Retamales, and J. Robeson. 2008. Bacteriophage treatment reduces Salmonella colonization of infected chickens. Avian Dis 52:64-67.
Borysowski, J. and A. Górski. 2008. Is phage therapy acceptable in the immunocompromised host? Int. J. Infect. Dis. 12:466-471. review
Cairns, B. J. and R. J. H. Payne. 2008. Bacteriophage therapy and the mutant selection window. Antimicrob. Agents Chemother. 52:4344-4350.
Callaway, T. R., T. S. Edrington, A. D. Brabban, R. C. Anderson, M. L. Rossman, M. J. Engler, M. A. Carr, K. J. Genovese, J. E. Keen, M. L. Looper, E. M. Kutter, and D. J. Nisbet. 2008. Bacteriophage isolated from feedlot cattle can reduce Escherichia coli O157:H7 populations in ruminant gastrointestinal tracts. Foodborne Pathog. Dis. 5:183-191.
Chanishvili, N. and R. Sharp. 2008. Bacteriophage therapy: experience from the Eliava Institute, Georgia. Microbiol. Aust. 29:96-101. review
Chhibber, S., S. Kaur, and S. Kumari. 2008. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J. Med. Microbiol. 57:1508-1513.
Comeau, A. M., F. Tétart, S. N. Trojet, M. F. Prère, and H. M. Krisch. 2008. [The discovery of a natural phenomenon, "phage-antibiotic synergy". Implications for phage therapy]. Med. Sci. (Paris) 24:449-451.
Connerton, I. F., P. L. Connerton, P. Barrow, B. S. Seal, and R. J. Atterbury. 2008. Bacteriophage therapy and Campylobacter, p. 679-693. In: I. Nachamkin, C. M. Szymanski, and M. J. Blaser (eds.), Campylobacter. 3rd ed. ASM Press, New York. review
Debarbieux, L. 2008. [Experimental phage therapy in the beginning of the 21st century]. Med. Mal Infect. 38:421-425. review
Donlan, R. M. 2008. Biofilms on central venous catheters: is eradication possible? Curr. Top. Microbiol. Immunol. 322:133-161. [Local Link] review
Dublanchet, A. and E. Fruciano. 2008. [A short history of phage therapy]. Med. Mal Infect. 38:415-420. review
Dublanchet, A. and O. Patey. 2008. [Bacterial infection—update on phage therapy]. Med. Mal Infect. 38:407-409. review
Fortuna, W., R. Miedzybrodzki, B. Weber-Dabrowska, and A. Górski. 2008. Bacteriophage therapy in children: facts and prospects. Med. Sci. Monit. 14:RA126-RA132. review
Garcia, P. B., B. Martinez, J. M. Obeso, and A. Rodriquez. 2008. Bacteriophages and their application in food safety. Lett. Appl. Microbiol. 47:479-485. review
Gill, J. J. 2008. Modeling of bacteriophage therapy, p. 439-464. In: S. T. Abedon (ed.), Bacteriophage Ecology. Cambridge University Press, Cambridge, UK. review
Goodridge, L. and S. T. Abedon. 2008. Bacteriophage biocontrol—the technology matures. Microbiol. Aust. 29:48-49. review
Hagens, S. and M. I. Offerhaus. 2008. Bacteriophages, new weapons for food safety. Food Technology 62:46-54. review
Hurley, A., J. J. Maurer, and M. D. Lee. 2008. Using bacteriophages to modulate Salmonella colonization of the chicken's gastrointestinal tract: lessons learned from in silico and In vivo modeling. Avian Dis 52:599-607.
Johnson, R. P., C. L. Gyles, W. E. Huff, S. Ojha, G. R. Huff, N. C. Rath, and A. M. Donoghue. 2008. Bacteriophages for prophylaxis and therapy in cattle, poultry and pigs. An. Hlth. Res. Rev. 9:201-215. review
Kim, K.-P., J.-D. Cha, E.-H. Jang, J. Klumpp, S. Hagens, W.-D. Hardt, K.-Y. Lee, and M. J. Loessner. 2008. PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response. Microb. Biotechnol. 1:247-257.
Knezevic, P. and O. Petrovic. 2008. A colorimetric microtiter plate method for assessment of phage effect on Pseudomonas aeruginosa biofilm. J. Microbiol. Meth. 74:114-118.
Kutateladze, M. and R. Adamia. 2008. Phage therapy experience at the Eliava Institute. Med. Mal Infect. 38:426-430. review
Kutter, E. 2008. Phage therapy: bacteriophages as naturally occurring antimicrobials, p. 713-730. In: E. Goldman and L. H. Green (eds.), Practical Handbook of Microbiology. CRC Press, Boca Raton,FL. review
Leszczynski, P., B. Weber-Dabrowska, M. Kohutnicka, M. Luczak, A. Górecki, and A. Górski. 2008. Successful eradication of methicillin-resistant Staphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker - a case report. Folia Microbiol. 51:236-238.
Ma, Y., J. C. Pacan, Q. Wang, Y. Xu, X. Huang, A. Korenevsky, and P. M. Sabour. 2008. Microencapsulation of bacteriophage Felix O1 into chitosan-alginate microspheres for oral delivery. Appl. Environ. Microbiol. 74:4799-4805.
Mann, N. H. 2008. The potential of phages to prevent MRSA infections. Res. Microbiol. 159:400-405. review
Mattey, M. and J. Spencer. 2008. Bacteriophage therapy—cooked goose or Phoenix rising? Curr. Opin. Biotechnol. 19:608-612. review
McLaughlin, M. R. and J. P. Brooks. 2008. EPA worst case water microcosms for testing phage biocontrol of Salmonella. J. Environ. Qual. 37:266-271.
Nishikawa, H., M. Yasuda, J. Uchiyama, M. Rashel, Y. Maeda, I. Takemura, S. Sugihara, T. Ujihara, Y. Shimizu, T. Shuin, and S. Matsuzaki. 2008. T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections. Arch. Virol. 153:507-515.
Parisien, A., B. Allain, J. Zhang, R. Mandeville, and C. Q. Lan. 2008. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J. Appl. Microbiol. 104:1-13. review
Sillankorva, S., R. Oliveira, M. J. Vieira, and J. Azeredo. 2008. Real-time quantification of Pseudomonas fluorescens cell removal from glass surfaces due to bacteriophage φS1 application. J. Appl. Microbiol. 105:196-202.
Sillankorva, S., P. Neubauer, and J. Azeredo. 2008. Pseudomonas fluorescens biofilms subjected to phage phiIBB-PF7A. BMC Biotechnol. 8:79.
Uchiyama, J., M. Rashel, I. Takemura, H. Wakiguchi, and S. Matsuzaki. 2008. In silico and In vivo evaluation of bacteriophage φEF24C, a candidate for treatment of Enterococcus faecalis infections. Appl. Environ. Microbiol. 74:4149-4163.
van Bergen, M. and J. Wagenaar. 2008. [Phage therapy: harmless viruses help destroy bacterial infections]. Tijdschrift Voor Diergeneeskunde 133:618-621. review
Vinodkumar, C. S., S. Kalsurmath, and Y. F. Neelagund. 2008. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice. Indian J. Pathol. Microbiol. 51:360-366.
Yacoby, I. and I. Benhar. 2008. Targeted filamentous bacteriophages as therapeutic agents. Expert Opin Drug Deliv 5:321-329. review
Zuber, S., C. Boissin-Delaporte, L. Michot, C. Iversen, B. Diep, H. Brüssow, and P. Breeuwer. 2008. Decreasing Enterobacter sakazakii (Cronobacter spp.) food contamination level with bacteriophages: prospects and problems. Microb. Biotechnol. 1:532-543.
Atterbury, R. J., M. A. P. Van Bergen, F. Ortiz, M. A. Lovell, J. A. Harris, A. De Boer, J. A. Wagenaar, V. M. Allen, and P. A. Barrow. 2007. Bacteriophage therapy to reduce Salmonella colonization of broiler chickens. Appl. Environ. Microbiol. 73:4543-4549.
Brüssow, H. 2007. Phage therapy: the Western perspective, p. 159-192. In: S. Mc Grath and D. van Sinderen (eds.), Bacteriophage: Genetics and Microbiology. Caister Academic Press, Norfolk, UK. review
Capparelli, R., M. Parlato, G. Borriello, P. Salvatore, and D. Iannelli. 2007. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob. Agents Chemother. 51:2765-2773.
Cerca, N., R. Oliveria, and J. Azeredo. 2007. Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of Staphylococcus bacteriophage K. Lett. Appl. Microbiol. 45 :313-317.
Defoirdt, T., N. Boon, P. Sorgeloos, W. Verstraete, and P. Bossier. 2007. Alternatives to antibiotics to control bacterial infections: luminescent vibriosis in aquaculture as an example. Trends in Biotechnolgoy 25:472-479. review
Del Pozo, J. L., M. Alonso, C. R. Arciola, R. Gonzalez, J. Leiva, I. Lasa, and J. Penades. 2007. Biotechnological war against biofilms. Could phages mean the end of device-related infections? Int. J. Artif. Organs 30:805-812. review
Dublanchet, A. and S. Bourne. 2007. The epic of phage therapy. Can. J. Infect. Dis. Med. Microbiol. 18:15-18. review
Dzuliashvili, M., K. Gabitashvili, A. Golidjashvili, N. Hoyle, and K. Gachechiladze. 2007. Study of therapeutic potential of the experimental Pseudomonas bacteriophage preparation. Georgian Med. News 81-88.
Efrony, R., Y. Loya, E. Bacharach, and E. Rosenberg. 2007. Phage therapy of coral disease. Coral Reefs 26:7-13.
Eyer, L., R. Pantucek, V. Ruzickova, and J. Doskar. 2007. [New perspectives of the phage therapy]. Klinicka mikrobiologie a infekc???aring;ni lekar???aring???stvi 13:231-235. review
Filho, R. L. A., J. P. Higgins, S. E. Higgins, G. Gaona, A. D. Wolfenden, G. Tellez, and B. M. Hargis . 2007. Ability of bacteriophages isolated from different sources to reduce Salmonella enterica serovar Enteritidis in vitro and In vivo. Poult. Sci. 86:1904-1909.
Fruciano, D. E. and S. Bourne. 2007. Phage as an antimicrobial agent: d'Herelle's heretical theories and their role in the decline of phage prophylaxis in the West. Can. J. Infect. Dis. Med. Microbiol. 18:19-26.
Gill, J. J., T. Hollyer, and P. M. Sabour. 2007. Bacteriophages and phage-derived products as antibacterial therapeutics. Expert Opin. Ther. Pat. 17:1341-1350. review
Górski, A., J. Borysowski, R. Miedzybrodzki, and B. Weber-Dabrowska. 2007. Bacteriophages in medicine, p. 125-158. In: S. Mc Grath and D. van Sinderen (eds.), Bacteriophage: Genetics and Microbiology. Caister Academic Press, Norfolk, UK. review
Hagens, S. and M. J. Loessner. 2007. Application of bacteriophages for detection and control of foodborne pathogens. Appl. Microbiol. Biotechnol. 76:513-519. review
Hanlon, G. W. 2007. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int. J. Antimicrob. Agents 30:118-128. review
Hermoso, J. A., J. L. Garcia, and P. Garcia. 2007. Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Curr. Opin. Mirobiol. 10 :461-472. review
Higgins, S. E., J. P. Higgins, L. R. Bielke, and B. M. Hargis. 2007. Selection and application of bacteriophages for treating Salmonella enteritidis infections in poultry. Int. J. Poult. Sci. 6:163-168.
Hong, Y. P. and W. S. Conway. 2007. Combined application of bacteriophage and Gluconobacter asai in reducing Listeria monocytogenes in honeydew melon pieces. Hort. Environ. Biotechnol. 48:365-369.
Ingram, D. M., S. Lu, and C. W. Meister. 2007. Evaluation of bactericidal, biological and antibiotic products for the control of bacterial canker in greenhouse tomatoes. Plant Health Progress.
Jones, J. B., L. E. Jackson, B. Balogh, A. Obradovic, F. B. Iriarte, and M. T. Momol. 2007. Bacteriophages for plant disease control. Ann. Rev. Phytopathol. 45:245-262. review
Kim, K. P., J. Klumpp, and M. J. Loessner. 2007. Enterobacter sakazakii bacteriophages can prevent bacterial growth in reconstituted infant formula. Int. J. Food Microbiol. 115:195-203.
Kumar, V., S. Balaji, N. S. Gomathi, P. Venkatesan, G. Sekar, K. Jayasankar, and P. R. Narayanan. 2007. Phage cocktail to control the exponential growth of normal flora in processed sputum specimens grown overnight in liquid medium for rapid TB diagnosis. J. Microbiol. Meth. 68:536-542.
Kurtboke, D. I. and J. R. J. French. 2007. Use of phage battery to investigate the actinofloral layers of termite gut microflora. J. Appl. Microbiol. 103:722-734.
Kysela, D. T. and P. E. Turner. 2007. Optimal bacteriophage mutation rates for phage therapy. J. Theor. Biol. 249:411-421.
Lang, J. M., D. H. Gent, and H. F. Schwartz. 2007. Management of Xanthomonas leaf blight of onion with bacteriophages and a plant activator. Plant Dis. 91:871-878.
LeJeune, J. T. and A. N. Wetzel. 2007. Preharvest control of Escherichia coli O157 in cattle. J. Anim. Sci. 85:E73-E80. [Local Link] review
Lu, T. K. and J. J. Collins. 2007. Dispersing biofilms with engineered enzymatic bacteriophage. Proc. Natl. Acad. Sci. USA 104:11197-11202.
McVay, C. S., M. Velasquez, and J. A. Fralick. 2007. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob. Agents Chemother. 51:1934-1938.
Miedzybrodzki, R., W. Fortuna, B. Weber-Dabrowska, and A. Górski. 2007. Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment. Postepy higieny i medycyny doswiadczalnej (Online) 61:461-465.
Paradis-Bleau, C., I. Cloutier, L. Lemieux, F. Sanschagrin, J. +. Laroche, M. l. Auger, A. Garnier, and R. C. Levesque. 2007. Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage phiKZ gp144 lytic transglycosylase. FEMS Microbiol. Lett. 266:201-209.
Petty, N. K., T. J. Evans, P. C. Fineran, and G. P. C. Salmond. 2007. Biotechnological exploitation of bacteriophage research. Trends Biotechnol. 25:7-15. review
Ravensdale, M., T. J. Blom, J. A. Gracia-Garza, A. M. Svircev, and R. J. Smith. 2007. Bacteriophages and the control of Erwinia carotovora subsp carotovora. Can. J. Plant Pathol. 29:121-130.
Skurnik, M., M. Pajunen, and S. Kiljunen. 2007. Biotechnological challenges of phage therapy. Biotechnol. Lett. 29:995-1003. review
Union Biochimpharm. 2007. Study of therapeutic potential of the experimental Pseudomonas bacteriophage preparation. Georgian Med. News. ???
Verbeken, G., D. De Vos, M. Vaneechoutte, M. Merabishvili, M. Zizi, and J.-P. Pirnay. 2007. European regulatory conundrum of phage therapy. Future Microbiol. 2:485-491. review
Vermeiren, L., F. DevIieghoere, D. de Meester, M. Schellekens, S. Hagens, and J. Debevere. 2007. Biological approach to reduce Listeria. Fleischwirtschaft International ???:97-100.
Von Jagow, C. and T. Teufer. 2007. Which path to go? On how to find a passage for innovations through the jungle of EU-food Law – discussed by the example of bacteriophages. European Food and Feed Law Review 3:136-145. review
Watanabe, R., T. Matsumoto, G. Sano, Y. Ishii, K. Tateda, Y. Sumiyama, J. Uchiyama, S. Sakurai, S. Matsuzaki, S. Imai, and K. Yamaguchi. 2007. Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob. Agents Chemother. 51:446-452.
Yacoby, I., H. Bar, and I. Benhar. 2007. Targeted drug-carrying bacteriophages as antibacterial nanomedicines. Antimicrob. Agents Chemother. 51:2156-2163.
Anisimov, A. P. and K. K. Amoako. 2006. Treatment of plague: promising alternatives to antibiotics. J. Med. Microbiol. 55:1461-1475. review
Bull, J. J. and R. R. Regoes. 2006. Pharmacodynamics of non-replicating viruses, bacteriocins and lysins. Proc. R. Soc. Lond. B Biol. Sci. 273:2703-2712. review
Capparelli, R., I. Ventimiglia, S. Roperto, D. Fenizia, and D. Iannelli. 2006. Selection of an Escherichia coli O157:H7 bacteriophage for persistence in the circulatory system of mice infected experimentally. Clin. Microbiol. Infect. 12:248-253.
Clark, J. R. and J. B. March. 2006. Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol. 24:212-218. review
Curtin, J. J. and R. M. Donlan. 2006. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob. Agents Chemother. 50:1268-1275.
Danelishvili, L., L. S. Young, and L. E. Bermudez. 2006. In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium. Microb. Drug Res. 12:1-6.
Fischetti, V. A., D. Nelson, and R. Schuch. 2006. Reinventing phage therapy: are the parts greater than the sum? Nat. Biotech. 24:1508-1511. review
Gill, J. J., P. M. Sabour, K. E. Leslie, and M. W. Griffiths. 2006. Bovine whey proteins inhibit the interaction of Staphylococcus aureus and bacteriophage K. J. Appl. Microbiol. 101:377-386.
Gill, J. J., J. C. Pacan, M. E. Carson, K. E. Leslie, M. W. Griffiths, and P. M. Sabour. 2006. Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob. Agents Chemother. 50:2912-2918.
Górski, A., E. Wazna, B.-W. Dabrowska, K. Switala-Jelén, and R. Miedzybrodzki. 2006. Bacteriophage translocation. FEMS Immunol. Med. Microbiol. 46:313-319. review
Hagens, S., A. Habel, and U. Blasi. 2006. Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage. Microb. Drug Resist. 12 :164-168.
sHarper, D. R. 2006. Biological control by microorganisms, p. 1-10. In: The Encyclopedia of Life Sciences. John Wiley & Sons, Chichester. review
Häusler, T. 2006. Viruses vs. Superbugs: A Solution to the Antibiotic Crisis. Macmillan. review
Hudson, J. A., C. Billington, and T. Bigwood. 2006. Phage inactivation of foodborne bacteria. Food Australia 58:593-595. review
Huff, W. E., G. R. Huff, N. C. Rath, and A. M. Donoghue. 2006. Evaluation of the influence of bacteriophage titer on the treatment of colibacillosis in broiler chickens. Poult. Sci. 85:1373-1377.
Imbeault, S., S. Parent, M. Lagace, C. F. Uhland, and J. F. Blais. 2006. Using bacteriophages to prevent furunculosis caused by Aeromonas salmonicida in farmed brook trout. J. Aquatic Animal Health 18:203-214.
Jain, R., A. L. Knorr, J. Bernacki, and R. Srivastava. 2006. Investigation of bacteriophage MS2 viral dynamics using model discrimination analysis and the implications for phage therapy. Biotechnol. Prog. 22:1650-1658.
Kropinski, A. M. 2006. Phage therapy - everything old is new again. Can. J. Infect. Dis. 17:297-306. review
Leszczynski, P., B. Weber-Dabrowska, M. Kohutnicka, M. Luczak, A. Gorecki, and A. Górski. 2006. Successful eradication of methicillin-resistant Staphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker—case report. Folia Microbiol. (Praha) 51:236-238.
Marza, J. A. S., J. S. Soothill, P. Boydell, and T. A. Collyns. 2006. Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients. Burns 32:644-646.
Merril, C. R., D. Scholl, and S. Adhya. 2006. Phage therapy, p. 725-741. In: R. Calendar and S. T. Abedon (eds.), The Bacteriophages. 2 ed. Oxford University Press, Oxford. review
Przerwa, A., M. Zimecki, K. Switala-Jelen, K. Dabrowska, E. Krawczyk, M. Luczak, B. Weber-Dabrowska, D. Syper, R. Miedzybrodzki, and A. Górski. 2006. Effects of bacteriophages on free radical production and phagocytic functions. Med. Microbiol. Immunol. 195:143-150.
Raya, R. R., P. Varey, R. A. Oot, M. R. Dyen, T. R. Callaway, T. S. Edrington, E. M. Kutter, and A. D. Brabban. 2006. Isolation and characterization of a new T-even bacteriophage, CEV1, and determination of its potential to reduce Escherichia coli O157:H7 levels in sheep. Appl. Environ. Microbiol. 72:6405-6410.
Rees, C. E. D. and C. E. R. Dodd. 2006. Phage for rapid detection and control of bacterial pathogens in food. Adv. Appl. Microbiol. 59:159-186. review
Sandeep, K. 2006. Bacteriophage precision drug against bacterial infections. Curr. Sci. 90:361-363. review
Sheng, H., H. J. Knecht, I. T. Kudva, and C. J. Hovde. 2006. Application of bacteriophages to control intestinal Escherichia coli O157:H7 levels in ruminants. Appl. Environ. Microbiol. 72:5359-5366.
Skurnik, M. and E. Strauch. 2006. Phage therapy: facts and fiction. Int. J. Med. Microbiol. 296:5-14. review
Wagenaar, J. A., D. J. Mevius, and A. H. Havelaar. 2006. Campylobacter in primary animal production and control strategies to reduce the burden of human campylobacteriosis. Rev. Sci. Tech. 25:581-594. review
Wang, J., B. Hu, M. Xu, Q. Yan, S. Liu, X. Zhu, Z. Sun, E. Reed, L. Ding, J. Gong, Q. Q. Li, and J. Hu. 2006. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. Int J Mol Med 17:309-317.
Wang, J., B. Hu, M. Xu, Q. Yan, S. Liu, X. Zhu, Z. Sun, D. Tao, L. Ding, E. Reed, J. Gong, Q. Q. Li, and J. Hu. 2006. Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia. Int J Mol Med 17:347-355.
Weber-Dabrowska, B., M. Zimecki, M. Kruzel, I. Kochanowska, and M. Lusiak-Szelachowska. 2006. Alternative therapies in antibiotic-resistant infection. Adv. Med. Sci. 51:242-244. review
Weitz, J. S. and H. Hartman. 2006. Phage in the time of cholera. Lancet Infect. Dis. 6:257-258. review
Yacoby, I., M. Shamis, H. Bar, D. Shabat, and I. Benhar. 2006. Targeting antibacterial agents by using drug-carrying filamentous bacteriophages. Antimicrob. Agents Chemother. 50:2087-2097.
Yoshida, T., Y. Takashima, Y. Tomaru, Y. Shirai, Y. Takao, S. Hiroishi, and K. Nagasaki. 2006. Isolation and characterization of a cyanophage infecting the toxic cyanobacterium Microcystis aeruginosa Appl. Environ. Microbiol. 72:1239-1247.
2005 Phage Therapy Publications
Borysowski, J., B. Weber-Dabrowska, and A. Górski. 2005. [The potential use of bacteriophages in view of the current antibiotic therapy crisis]. Polskie Archiwum Medycyny Wewnetrznej 113:73-78. review
Bruttin, A. and H. Brüssow. 2005. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob. Agents Chemother. 49:2874-2878.
Brüssow, H. 2005. Phage therapy: the Escherichia coli experience. Microbiology 151:2133-2140. review
Carlton, R. M., W. H. Noordman, B. Biswas, E. D. de Meester, and M. J. Loessner. 2005. Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul. Toxicol. Pharm. 43:301-312.
Connerton, P. and I. Connerton. 2005. Natural Campylobacter control with bacteriophage, p. 25-26. In: World Poultry Salmonella & Campylobacter Special. review
Dabrowska, K., K. Switala-Jelén, A. Opolski, B. Weber-Dabrowska, and A. Górski. 2005. Bacteriophage penetration in vertebrates. J. Appl. Microbiol. 98:7-13. review
Damasko, C., A. Konietzny, H. Kaspar, B. Appel, P. Dersch, and E. Strauch. 2005. Studies of the efficacy of enterocoliticin, a phage-tail like bacteriocin, as antimicrobial agent against Yersinia enterocolitica serotype O3 in a cell culture system and in mice. J. Vet. Med. B. Infect. Dis. Vet. Pub. Health 52:171-179.
Dickerson, T. J., G. F. Kaufmann, and K. D. Janda. 2005. Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy. Expert Opin. Biol. Ther. 5:773-781. review
Fiorentin, L., N. D. Vieira, and W. J. Barioni. 2005. Oral treatment with bacteriophages reduces the concentration of Salmonella enteritidis PT4 in caecal contents of broilers. Avian Pathol. 34:258-263.
Gent, D. H. and H. F. Schwartz. 2005. Management of Xanthomonas leaf blight of onion with a plant activator, biological control agents, and copper bactericides. Plant Dis. 89:631-639.
Górski, A. and B. Weber-Dabrowska. 2005. The potential role of endogenous bacteriophages in controlling invading pathogens. Cell. Mol. Life Sci. 62:511-519.
Greer, G. G. 2005. Bacteriophage control of foodborne bacteria. J. Food Prot. 68:1102-1111. review
Gvasalia, G., Z. Alavidze, Meifariani, and Dzneladze. 2005. Phage prophylactics and phage therapy of surgical infections, p. 108-109. In: From rare cases to global problems. Tbilisi Georgia. review
Gvasalia, G., Z. Alavidze, A. Meipariani, and Dvidzishvili. 2005. Using bacteriophages for processing of purulent wounds caused by gunshots, p. 47-48. In: "Perspectives of bacteriophage preparations for prevention and treatment of infections caused by pathogenic and facultatively pathogenic microorganisms. Tbilisi, Georgia. review
Hanlon, G. 2005. Bacteriophage therapy. A once and future solution? Biomed. Scient. October:1048-1052. review
Higgins, J. P., S. E. Higgins, K. L. Guenther, W. Huff, A. M. Donoghue, D. J. Donoghue, and B. M. Hargis. 2005. Use of a specific bacteriophage treatment to reduce Salmonella in poultry products. Poult. Sci. 84:1141-1145.
Hudson, J. A., C. Billington, G. Carey-Smith, and G. Greening. 2005. Bacteriophages as biocontrol agents in food. J. Food Prot. 68:426-437. review
Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Donoghue. 2005. Alternatives to antibiotics: utilization of bacteriophage to treat colibacillosis and prevent foodborne pathogens. Poult. Sci. 84:655-659.
Jikia, D., N. Chkhaidze, E. Imedashvili, I. Mgaloblishvili, G. Tsitlanadze, R. Katsarava, J. J. Glenn Morris, and A. Sulakvelidze. 2005. The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90. Clin. Exp. Dermatol. 30:23-26.
Kutter, E. 2005. Phage therapy: bacteriophages as natural, self-limiting antibiotics, p. 1147-1161. In: W. Pizzorno (ed.), Textbook of Natural Medicine, 3rd edition. Churchill Livingston. review
Loc Carrillo, C., R. J. Atterbury, A. El Shibiny, P. L. Connerton, E. Dillon, A. Scott, and I. F. Connerton. 2005. Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Appl. Environ. Microbiol. 71:6554-6563.
Matsuda, T., T. A. Freeman, D. W. Hilbert, M. Duff, M. Fuortes, P. P. Stapleton, and J. M. Daly. 2005. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model. Surgery 137:639-646.
Matsuzaki, S., M. Rashel, J. Uchiyama, S. Sakurai, T. Ujihara, M. Kuroda, M. Ikeuchi, T. Tani, M. Fujieda, H. Wakiguchi, and S. Imai. 2005. Bacteriophage therapy: a revitalized therapy against bacterial infectious disease. J. Infect. Chemother. 11:211-219. review
McKinstry, M. and R. Edgar. 2005. Use of phages in therapy and bacterial detection, p. 430-440. In: M. K. Waldor, D. I. Friedman, and S. L. Adhya (eds.), Phages: Their Role in Bacterial Pathogenesis and Biotechnology. ASM Press, Washington DC. review
McNerney, R. and H. Traore. 2005. Mycobacteriophage and their application to disease control. J. Appl. Microbiol. 99:223-233. review
O'Flaherty, S., R. P. Ross, W. Meaney, G. F. Fitzgerald, M. F. Elbreki, and A. Coffey. 2005. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl. Environ. Microbiol. 71:1836-1842.
Parfitt, T. 2005. Georgia: an unlikely stronghold for bacteriophage therapy. Lancet 365:2166-2167. review
Pelon, W., R. B. Luftig, and K. H. Johnston. 2005. Vibrio vulnificus load reduction in oysters after combined exposure to Vibrio vulnificus-specific bacteriophage and to an oyster extract component. J. Food Prot. 68:1188-1191.
Prokopenko, E. I., E. O. Shcherbakova, A. V. Vatazin, N. E. Budnikova, A. G. Iankovoi, S. A. Pasov, and S. G. Agafonova. 2005. [Bacteriophages use in the treatment of pyoseptic complications in a female patient with renal allotransplant]. Urologiia43-46.
Sharma, M., J. H. Ryu, and L. R. Beuchat. 2005. Inactivation of Escherichia coli O157:H7 in biofilm on stainless steel by treatment with an alkaline cleaner and a bacteriophage. J. Appl. Microbiol. 99:449-459.
Sulakvelidze, A. and E. Kutter. 2005. Bacteriophage therapy in humans, p. 381-436. In: E. Kutter and A. Sulakvelidze (eds.), Bacteriophages: Biology and Application. CRC Press, Boca Raton, Florida. review
Sulakvelidze, A. 2005. Phage therapy, p. 38-39. In: Novel Therapeutics for Enteric Diseases. Enteric and Hepatic Diseases Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases. review
Sulakvelidze, A. and P. Barrow. 2005. Phage therapy in animals and agribusiness, p. 335-380. In: E. Kutter and A. Sulakvelidze (eds.), Bacteriophages: Biology and Application. CRC Press, Boca Raton, Florida. review
Sulakvelidze, A. 2005. Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections. Drug Discov. Today 10:807-809. review
Summers, W. C. 2005. History of phage research and phage therapy, In: M. Waldor, D. Friedman, and S. Adhya (eds.), Phages: Their Role in Bacterial Pathogenesis and Biotechnology. ASM Press, Washington DC. review
Sutherland, I. W., K. A. Hughes, L. C. Skillman, and K. Tait. 2004. The interaction of phage and biofilms. FEMS Microbiol. Lett. 232:1-6. [Local Link] review
Tanji, Y., T. Shimada, H. Fukudomi, K. Miyanaga, Y. Nakai, and H. Unno. 2005. Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice. J. Biosci. Bioeng. 100:280-287.
Toro, H., S. B. Price, A. S. McKee, F. J. Hoerr, J. Krehling, M. Perdue, and L. Bauermeister. 2005. Use of bacteriophages in combination with competitive exclusion to reduce Salmonella from infected chickens. Avian Dis 49:118-124.
Vinodkumar, C. S., Y. F. Neelagund, and S. Kalsurmath. 2005. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae. J. Commun. Dis. 37:18-29.
Wagenaar, J. A., M. A. P. Van Bergen, M. A. Mueller, T. M. Wassenaar, and R. M. Carlton. 2005. Phage therapy reduces Campylobacter jejuni colonization in broilers. Vet. Microbiol. 109:275-283.
Wills, Q. F., C. Kerrigan, and J. S. Soothill. 2005. Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrob. Agents Chemother. 49:1220-1221.
Withey, S., E. Cartmell, L. M. Avery, and T. Stephenson. 2005. Bacteriophages—potential for application in wastewater treatment processes. Sci. Total Environ. 339:1-18. review
Xie, H., X. Zhuang, J. Kong, G. Ma, and H. Zhang. 2005. Bacteriophage Esc-A is an efficient therapy for Escherichia coli 3-1 caused diarrhea in chickens. J. Gen. Appl. Microbiol. 51:159-163.
Xu, Y., D. r. Peng, H. y. Xiong, X. n. Zhang, M. q. Su, Y. q. Sun, and X. k. Hao. 2005. [Study on the nucleic acid of E. coli bacteriophage with broad host range and its sterilization effect to sewage samples from the environment]. Zhonghua Liu Xing Bing Xue Za Zhi 26:356-360.
??? 2004. Some aspects of selection of treatment - prophylactic Serratia marcescens bacteriophages. Proceedings of the Georgian Academy of Sciences, Biology Series 25:787-797.
Benedict, L. R. N. and R. S. Flamiano. 2004. Use of bacteriophages as therapy for Escherichia coli-induced bacteremia in mouse models. Phil. J. Microbiol. Infect. Dis. 33:47-51.
Boratynski, J., D. Syper, B. Weber-Dabrowska, M. Lusiak-Szelachowska, G. Pozniak, and A. Górski. 2004. Preparation of endotoxin-free bacteriophages. Cell. Mol. Biol. Lett. 9:253-259.
Bradbury, J. 2004. "My enemy's enemy is my friend. " Using phages to fight bacteria. Lancet 363:624-625. review
Broxmeyer, L. 2004. Bacteriophages: antibacterials with a future? Med. Hypoth. 62:889-893. review
Carrera, M. R., G. F. Kaufmann, J. M. Mee, M. M. Meijler, G. F. Koob, and K. D. Janda. 2004. Treating cocaine addiction with viruses. Proc. Natl. Acad. Sci. USA 101:10416-10421.
Chibani-Chennoufi, S., J. Sidoti, A. Bruttin, E. Kutter, S. Sarker, and H. Brüssow. 2004. In vitro and In vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob. Agents Chemother. 48:2558-2569.
Connerton, P. L., C. M. Loc Carrillo, C. Swift, E. Dillon, A. Scott, C. E. D. Rees, C. E. R. Dodd, J. Frost, and I. F. Connerton. 2004. Longitudinal study of Campylobacter jejuni bacteriophage and their hosts from broiler chickens. Appl. Environ. Microbiol. 70:3877-3883.
Dabrowska, K., A. Opolski, J. Wietrzyk, K. Switala-Jelén, J. Godlewska, J. Boratynski, D. Syper, B. Weber-Dabrowska, and A. Górski. 2004. Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumour models. Anticanc. Res. 24:3991-3995.
Dabrowska, K., A. Opolski, J. Wietrzyk, K. Switala-Jelén, J. Boratynski, A. Nasulewicz, L. Lipinska, A. Chybicka, M. Kujawa, M. Zabel, B. Dolinska-Krajewska, E. Piasecki, B. Weber-Dabrowska, J. Rybka, J. Salwa, E. Wojdat, M. Nowaczyk, and A. Górski. 2004. Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of β3 integrin signaling pathway. Acta virologica. English ed 48:241-248.
Debattista, J. 2004. Phage therapy: where East meets West. Exp. Rev. Anti-Infect. Ther. 2:815-819. review
Dixon, B. 2004. New dawn for phage therapy. Lancet Infect. Dis. 4 :186. review
Duerr, D. M., S. J. White, and H. J. Schluesener. 2004. Identification of peptide sequences that induce the transport of phage across the gastrointestinal mucosal barrier. J. Virol. Meth. 116:177-180.
Emery, D. L. and R. J. Whittington. 2004. An evaluation of mycophage therapy, chemotherapy and vaccination for control of Mycobacterium avium subsp. paratuberculosis infection. Vet. Microbiol. 104:143-155. review
Fiorentin, L. F., N. D. Vieira, and S. Barros. 2004. 'In vivo' characterization and 'in vivo' properties of salmonellae lytic bacteriophages isolated from free-range layers. Braz. J. Poul. Sci. 6:105-112.
Goodridge, L. D. 2004. Bacteriophage biocontrol of plant pathogens: fact or fiction? Trends Biotechnol. 22:384-385. review
Hagens, S., A. Habel, U. von Ahsen, A. von Gabain, and U. Bläsi. 2004. Therapy of experimental Pseudomonas infections with a nonreplicating genetically modified phage. Antimicrob. Agents Chemother. 48:3817-3822.
Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Donoghue. 2004. Therapeutic efficacy of bacteriophage and Baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers. Poult. Sci. 83:1944-1947.
Leverentz, B., W. S. Conway, W. Janisiewicz, and M. J. Camp. 2004. Optimizing concentration and timing of a phage spray application to reduce Listeria monocytogenes on honeydew melon tissue. J. Food Prot. 67:1682-1686.
Levin, B. R. and J. J. Bull. 2004. Population and evolutionary dynamics of phage therapy. Nat. Rev. Microbiol. 2:166-173. review
Lysiak, K. 2004. Bacteriophages as an alternative to antibiotics – possibilities of their practical usage in dental surgery – a review [text in Polish]. Dent. Med. Probl. 41:761-768. review
Mushtaq, N., M. B. Redpath, J. P. Luzio, and P. W. Taylor. 2004. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype. Antimicrob. Agents Chemother. 48:1503-1508.
O'Flynn, G., R. P. Ross, G. F. Fitzgerald, and A. Coffey. 2004. Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl. Environ. Microbiol. 70:3417-3424.
Obradovic, A., J. B. Jones, M. T. Momol, B. Balogh, and S. M. Olson. 2004. Management of tomato bacterial spot in the field by foliar applications of bacteriophages and SAR inducers. Plant Dis. 88:736-740.
Paisano, A. F., B. Spira, B. Cai, and A. C. Bombana. 2004. In vitro antimicrobial effect of bacteriophages on human dentin infected with Enterococcus faecalis ATCC 29212. Oral Microbiol. Immunol. 19:327-330.
Pao, S., S. P. Randolph, E. W. Westbrook, and H. Shen. 2004. Use of bacteriophages to control Salmonella in experimentally contaminated sprout seeds. J. Food Sci. 69:M127-M130.
Projan, S. 2004. Phage-inspired antibiotics? Nat. Biotech. 22:167-168. review
Projan, S. 2004. Response: Phage offer a real alternative. Nat. Biotech. 22:506-507. review
Sajjad, M., S. U. Rahman, I. Hussain, and M. H. Rasool. 2004. Application of coliphage lysate: a preliminary trial to treat an experimental Escherichia coli infection in broiler chicken. J. Poult. Sci. 3:538-542.
Santander, J. and J. Robeson. 2004. Bacteriophage prophylaxis against Salmonella enteritidis and Salmonella pullorum using Caenorhabditis elegans as an assay system. Electr. J. Biotechnol. 7:208-211.
Schoolnik, G. K., W. C. Summers, and J. D. Watson. 2004. Phage offer a real alternative. Nat. Biotech. 22:505-506. review
Shasha, S. M., N. Sharon, and M. Inbar. 2004. [Bacteriophages as antibacterial agents]. Harefuah 143:121-5, 166. review
Sillankorva, S., R. Oliveira, M. J. Vieira, I. W. Sutherland, and J. Azeredo. 2004. Bacteriophage Φ S1 infection of Pseudomonas fluorescens planktonic cells versus biofilms. Biofouling 20:133-138.
Soothill, J., C. Hawkins, E. Anggard, and D. Harper. 2004. Therapeutic use of bacteriophages. Lancet Infect. Dis. 4:544-545. review
Tanji, Y., T. Shimada, M. Yoichi, K. Miyanaga, K. Hori, and H. Unno. 2004. Toward rational control of Escherichia coli O157:H7 by a phage cocktail. Appl. Microbiol. Biotechnol. 64:270-274.
Thiel, K. 2004. Old dogma, new tricks—21st Century phage therapy. Nat. Biotech. 22:31-36. review
Weld, R. J., C. Butts, and J. A. Heinemann. 2004. Models of phage growth and their applicability to phage therapy. J. Theor. Biol. 227:1-11.
Atterbury, R. J., P. L. Connerton, C. E. R. Dodd, C. E. D. Rees, and I. F. Connerton. 2003. Application of host-specific bacteriophages to the surface of chicken skin leads to a reduction in recovery of Campylobacter jejuni. Appl. Environ. Microbiol. 69:6302-6306.
Bach, S. J., T. A. McAllister, D. M. Veira, V. P. J. Gannon, and R. A. Holley. 2003. Effect of bacteriophage DC22 on Escherichia coli O157:H7 in an artificial rumen system (Rusitec) and inoculated sheep. Anim. Res. 52:98-101.
Balogh, B., J. B. Jones, M. T. Momol, S. M. Olson, A. Obradovic, and L. E. Jackson. 2003. Improved efficacy of newly formulated bacteriophages for management of bacterial spot on tomato. Plant Dis. 87:949-954.
Goode, D., V. M. Allen, and P. A. Barrow. 2003. Reduction of experimental Salmonella and Campylobacter contamination of chicken chicken skin by application of lytic bacteriophages. Appl. Environ. Microbiol. 69:5032-5036.
Gill, J. J. and S. T. Abedon. 2003. Bacteriophage ecology and plants. APSNet Feature http://www.apsnet.org/publications/apsnetfeatures/Pages/BacteriophageEcology.aspx. review
Goodridge, L. and S. T. Abedon. 2003. Bacteriophage biocontrol and bioprocessing: application of phage therapy to industry. SIM News 53:254-262. review
Górski, A., K. Dabrowska, K. Switala-Jelén, M. Nowaczyk, B. Weber-Dabrowska, J. Boratynski, J. Wietrzyk, and A. Opolski. 2003. New insights into the possible role of bacteriophages in host defense and disease. Med. Immunol. 2:2. review
Górski, A., M. Nowaczyk, B. Weber-Dabrowska, M. Kniotek, J. Boratynski, A. Ahmed, K. Dabrowska, P. Wierzbicki, K. Switala-Jelén, and A. Opolski. 2003. New insights into the possible role of bacteriophages in transplantation. Transplant. Proc. 35:2372-2373. review
Hagens, S. and U. Bläsi. 2003. Genetically modified filamentous phage as bactericidal agents: a pilot study. Lett. Appl. Microbiol. 37:318-323.
Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Donoghue. 2003. Bacteriophage treatment of a severe Escherichia coli respiratory infection in broiler chickens. Avian Dis 47:1399-1405. review
Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Donoghue. 2003. Evaluation of aerosol spray and intramuscular injection of bacteriophage to treat an Escherichia coli respiratory infection. Poult. Sci. 82:1108-1112.
Huovinen, P. 2003. [Bacteriophage therapy]. Duodecim; laaketieteellinen aikakauskirja 119:581-583. review
Inal, J. M. 2003. Phage therapy: a reappraisal of bacteriophages as antibiotics. Arch. Immunol. Ther. Exp. 51:237-244. review
Joerger, R. D. 2003. Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poult. Sci. 82:640-647. review
Kaulen, H. 2003. [Bacteriophage therapy: Stalin's forgotten medicine]. Deutsche medizinische Wochenschrift 128:307. review
Lazareva, E. B. 2003. [Bacteriophages for treatment and prophylaxis of infectious diseases]. Antibiot. Khimoter. 48:36-40. review
Leverentz, B., W. S. Conway, M. J. Camp, W. J. Janisiewicz, T. Abuladze, M. Yang, R. Saftner, and A. Sulakvelidze. 2003. Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Appl. Environ. Microbiol. 69:4519-4526.
Mandeville, R., M. Griffiths, L. Goodridge, L. McIntyre, and T. T. Ilenchuk. 2003. Diagnostic and therapeutic applications of lytic phages. Anal. Lett. 36:3241-3259. review
Mathur, M. D., S. Vidhani, and P. L. Mehndiratta. 2003. Bacteriophage therapy: an alternative to conventional antibiotics. J. Ass. Phys. India 51 :593-596. review
Matsuzaki, S., M. Yasuda, H. Nishikawa, M. Kuroda, T. Ujihara, T. Shuin, Y. Shen, Z. Jin, S. Fujimoto, M. D. Nasimuzzaman, H. Wakiguchi, S. Sugihara, T. Sugiura, S. Koda, A. Muraoka, and S. Imai. 2003. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage MR11. J. Infect. Dis. 187:613-624.
Merril, C. R., D. Scholl, and S. L. Adhya. 2003. The prospect for bacteriophage therapy in Western Medicine. Nat. Rev. 2:489-497. review
Nevasaari, K. 2003. [Bacteriophage therapy and colleague Martin Arrowsmith]. Duodecim; laaketieteellinen aikakauskirja 119:1367. review
Park, S. C. and T. Nakai. 2003. Bacteriophage control of Pseudomonas plecoglossicida infection in ayu Plecoglossus altivelis. Dis. Aquat. Org. 53:33-39.
Payne, R. J. H. and V. A. A. Jansen. 2003. Pharmacokinetic principles of bacteriophage therapy. Clin. Pharmacokinet. 42:315-325. review
Platt, R., D. L. Reynolds, and G. J. Phillips. 2003. Development of a novel method of lytic phage delivery by use of a bacteriophage P22 site-specific recombination system. FEMS Microbiol. Lett. 223:259-265.
Ronda, C., M. Vázquez, and R. López. 2003. [Bacteriophages as tool to fight against infections in Aquaculture] Los bacteriófagos como herramienta para combatir infecciones en acuicultura [abstract is in English, manuscript is in Spanish]. Revista AquaTIC 18:3-10.
Thacker, P. D. 2003. Set a microbe to kill a microbe: drug resistance renews interest in phage therapy. J. Am. Med. Assoc. 290:3183-3185. review
Walter, M. H. 2003. Efficacy and durability of Bacillus anthracis bacteriophages used against spores. J. Environ. Health 66:9-15, 24.
Weber-Dabrowska, B., M. Mulczyk, and A. Górski. 2003. Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Transplant. Proc. 35:1385-1386.
Westwater, C., L. M. Kasman, D. A. Schofield, P. A. Werner, J. W. Dolan, M. G. Schmidt, and J. S. Norris. 2003. Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections. Antimicrob. Agents Chemother. 47:1301-1307.
Whichard, J. M., N. Sriranganathan, and F. W. Pierson. 2003. Suppression of Salmonella growth by wild-type and large-plaque variants of bacteriophage Felix O1 in liquid culture and on chicken frankfurters. J. Food Prot. 66:220-225.
Ahmad, S. I. 2002. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics. Med. Hypoth. 58:327-331.
Biswas, B., S. Adhya, P. Washart, B. Paul, A. N. Trostel, B. Powell, R. Carlton, and C. R. Merril. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70:204-210.
Broxmeyer, L., D. Sosnowskai, E. Miltner, O. Chacón, D. Wagner, J. McGarvey, R. G. Barletta, and L. E. Bermudez. 2002. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: A model for phage therapy of intracellular bacterial pathogens. J. Infect. Dis. 186:1155-1160.
Bull, J. J., B. R. Levin, T. DeRouin, N. Walker, and C. A. Bloch. 2002. Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol. 2:35.
Burkal'tseva, M. V., V. N. Krylov, E. A. Pleteneva, O. V. Shaburova, S. V. Krylov, G. Volkart, N. N. Sykilinda, L. P. Kurochkina, and V. V. Mesyanzhinov. 2002. Phenogenetic characterization of a group of giant φKZ-like bacteriophages of Pseudomonas aeruginosa. Rus. J. Genet. 38:1242-1250.
Burkal'tseva, M. V., V. N. Krylov, E. A. Pleteneva, O. V. Shaburova, S. V. Krylov, G. Volkart, N. N. Sykilinda, L. P. Kurochkina, and V. V. Mesianzhinov. 2002. [Phenogenetic characterization of a group of giant φKZ-like bacteriophages of Pseudomonas aeruginosa]. Genetika 38:1470-1479.
Cerveny, K. E., A. Depaola, D. H. Duckworth, and P. A. Gulig. 2002. Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infect. Immun. 70:6251-6262.
Duckworth, D. H. and P. A. Gulig. 2002. Bacteriophages: potential treatment for bacterial infections. BioDrugs 16:57-62. review
Dykes, G. A. and S. M. Moorhead. 2002. Combined antimicrobial effect of nisin and a listeriophage against Listeria monocytogenes in broth but not in buffer or on raw beef. Int. J. Food Microbiol. 73:71-81.
Frenkel, D. and B. Solomon. 2002. Filamentous phage as vector-mediated antibody delivery to the brain. Proc. Natl. Acad. Sci. USA 99:5675-5679.
Burkal'tseva, M. V., V. N. Krylov, E. A. Pleteneva, O. V. Shaburova, S. V. Krylov, G. Volkart, N. N. Sykilinda, L. P. Kurochkina, and V. V. Mesyanzhinov. 2002. Phenogenetic characterization of a group of giant φKZ-like bacteriophages of Pseudomonas aeruginosa. Rus. J. Genet. 38:1242-1250.
Garcia, E. and R. Lopez. 2002. [The bacteriophages and their gene products as antimicrobial agents]. Rev. Espan. Quimioter. 15:306-312.
Greer, G. G. and B. D. Dilts. 2002. Control of Brochothrix thermosphacta spoilage of pork adipose tissue using bacteriophages. J. Food Prot. 65:861-863.
Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Donoghue. 2002. Prevention of Escherichia coli infection in broiler chickens with a bacteriophage aerosol spray. Poult. Sci. 81:1486-1491.
Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, H. Xie, P. A. J. Moore, and A. M. Donoghue. 2002. Prevention of Escherichia coli respiratory infection in broiler chickens with bacteriophage (SPR02). Poult. Sci. 81:437-441.
Johnston, N. 2002. Viral Trojan horse for combating tuberculosis. Drug Discov. Today 7:333-335.
Kasman, L. M., A. Kasman, C. Westwater, J. Dolan, M. G. Schmidt, and J. S. Norris. 2002. Overcoming the phage replication threshold: a mathematical model with implications for phage therapy. J. Virol. 76:5557-5564.
Keel, C., Z. Ucurum, P. Michaux, M. Adrian, and D. Haas. 2002. Deleterious impact of a virulent bacteriophage on survival and biocontrol activity of Pseudomonas fluorescens strain CHAO in natural soil. Mol. Plant-Microbe Interact. 15:567-576.
Krylov, V. 2002. Phagotherapy: myths and realities. Rus. Acad. Sci. Pres. 4:40-46. review
Markoishvili, K., G. Tsitlanadze, R. Katsarava, J. G. Morris, Jr., and A. Sulakvelidze. 2002. A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. Int. J. Dermatol. 41:453-458.
McKenna, F., K. A. El Tarabily, S. Petrie, C. Chen, and B. Dell. 2002. Application of actinomycetes to soil to ameliorate water repellency. Lett. Appl. Microbiol. 35:107-112.
Nakai, T. and S. C. Park. 2002. Bacteriophage therapy of infectious disease in aquaculture. Res. Microbiol. 153:13-18. review
Resch, G. and J. Meyer. 2002. [Bacteriophages, a new perspective in the treatment of infectious diseases?] Les bactériophages, nouvelle perspective dans le traitement des maladies infectieuses?. Schweiz. Monatsschrift Zahnmed [Rev. Mens. Suisse Odontostomatol ???]. 112:643-645. review
Stone, R. 2002. Bacteriophage therapy. Food and agriculture: testing grounds for phage therapy. Science 298:730. review
Stone, R. 2002. Bacteriophage therapy. Stalin's forgotten cure. Science 298:728-731. review
Tait, K., L. C. Skilman, and I. W. Sutherland. 2002. The efficacy of bacteriophage as a method of biofilm eradication. Biofouling 18:305-311.
Weber-Dabrowska, B., M. Zimecki, M. Mulczyk, and A. Górski. 2002. Effect of phage therapy on the turnover and function of peripheral neutrophils. FEMS Immunol. Med. Microbiol. 34:135-138.
Barrow, P. A. 2001. The use of bacteriophages for treatment and prevention of bacterial disease in animals and animal models of human infection. J. Chem. Technol. Biotechnol. 76:677-682. review
Bhatia, R. S. 2001. Phage treatment: can we utilise it for certain infective diseases in India? J. Ass. Phys. India 49:590.
Chanishvili, N., T. Chanishvili, M. Tediashvili, and P. A. Barrow. 2001. Phages and their application against drug-resistant bacteria. J. Chem. Technol. Biotechnol. 76:689-699. review
Das, P. 2001. Bacteriophage therapy offers new hope for streptococcal infections. Lancet 357:938. review
Flaherty, J. E., B. K. Harbaugh, J. B. Jones, G. C. Somodi, and L. E. Jackson. 2001. H-mutant bacteriophages as a potential biocontrol of bacterial blight of geranium. Hortscience 36:98-100.
Ho, K. 2001. Bacteriophage therapy for bacterial infections: Rekindling a memory from the pre-antibiotics era. Perspect. Biol. Med. 44:1-16. review
Krylov, V. N. 2001. [Phagotherapy in terms of bacteriophage genetics: hopes, perspectives, safety, limitations]. Genetika 37:869-887. review
Krylov, V. N. 2001. Phage therapy in terms of bacteriophage genetics: Hopes, prospects, safety, limitations. Rus. J. Genet. 37:715-730. review
Kutter, E. 2001. Phage Therapy: Bacteriophage as Natural, Self-limiting Antibiotics. AstraZeneca Research Foundation India , India. review
Lakhno, V. M. and V. N. Bordunovskii. 2001. [Use of bacteriophage therapy in surgical practice]. Vestnik Khirurgii Imeni I. I. Grekova 160:122-125. review
Lazareva, E. B., S. V. Smirnov, V. B. Khvatov, T. G. Spiridonova, E. E. Bitkova, O. S. Darbeeva, L. M. Mayskaya, R. L. Parphenyuk, and D. D. Menshikov. 2001. Efficacy of bacteriophage use in complex treatment of the patients with burn wounds. Antibiot. Khimoter. 46:10-14.
Lee, N. and D. L. Harris. 2001. The effect of bacteriophage treatment to reduce the rapid dissemination of Salmonella typhimurium in pigs. Proc. Am. Ass. Swine Vet. 32:555-557.
Leverentz, B., W. S. Conway, Z. Alavidze, W. J. Janisiewicz, Y. Fuchs, M. J. Camp, E. Chighladze, and A. Sulakvelidze. 2001. Examination of bacteriophage as a biocontrol method for Salmonella on fresh-cut fruit: a model study. J. Food Prot. 64:1116-1121.
McKenna, F., K. A. El-Tarabily, G. E. S. T. Hardy, and B. Dell. 2001. Novel In vivo use of a polyvalent Streptomyces phage to disinfest Streptomyces scabies-infected seed potatoes. Plant Pathol. 50:666-675.
McNeil, D. L., S. Romero, J. Kandula, C. Stark, A. Stewart, and S. Larsen. 2001. Bacteriophages: a potential biocontrol agent against walnut blight (Xanthomonas campestris pv. juglandis). New Zealand Plant Protec. 54:220-224.
Modi, R., Y. Hirvi, A. Hill, and M. W. Griffiths. 2001. Effect of phage on survival of Salmonella enteritidis during manufacture and storage of cheddar cheese made from raw and pasteurized milk. J. Food Prot. 64:927-933.
Olsen, I., T. Handal, and P. Lokken. 2001. [Bacteria-killing viruses, Stalinists and "superbugs "]. Tidsskr Nor Laegeforen 121:3197-3200. review
Payne, R. J. H. and V. A. A. Jansen. 2001. Understanding bacteriophage therapy as a density-dependent kinetic process. J. Theor. Biol. 208:37-48.
Sharp, R. J. 2001. Bacteriophages: biology and history. J. Chem. Technol. Biotechnol. 76:667-672. review
Sklar, I. B. and R. D. Joerger. 2001. Attempts to utilize bacteriophage to combat Salmonella enterica serovar enteritidisinfection in chickens. J. Food Safety 21:15-29.
Sulakvelidze, A., Z. Alavidze, and J. G. Morris, Jr. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649-659. review
Sulakvelidze, A. and J. G. Morris, Jr. 2001. Bacteriophages as therapeutic agents. Ann. Med. 33:507-509. review
Summers, W. C. 2001. Bacteriophage therapy. Ann. Rev. Microbiol. 55:437-451. review
Weber-Dabrowska, B., M. Mulczyk, and A. Górski. 2001. Bacteriophage therapy for infections in cancer patients. Clin. Appl. Immunol. Rev. 1:131-134.
Wood, H. L., S. R. Holden, and R. Bayston. 2001. Susceptibility of Staphylococcus epidermidis biofilm in CSF shunts to bacteriophage attack. Eur. J. Ped. Surgery 11:S56-S57.
Borah, P. K., J. K. Jindal, and J. P. Verma. 2000. Integrated management of bacterial leaf spot of mungbean with bacteriophages of Xav and chemicals. J. Mycol. Plant Pathol. 30:19-21.
Cao, J., Y. Sun, T. Berglindh, B. Mellgard, Z. Li, B. Mardh, and S. Mardh. 2000. Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth. Biochim. Biophys. Acta 1474:107-113.
Flaherty, J. E., J. B. Jones, B. K. Harbaugh, G. C. Somodi, and L. E. Jackson. 2000. Control of bacterial spot on tomato in the greenhouse and field with h-mutant bacteriophages. Hortscience 35:882-884.
Fox, J. L. 2000. Phage treatments yield healthier tomato, pepper plants. ASM News 66:455-456.
Harris, D. L. 2000. Reduction of Salmonella by bacteriophage treatment – NPB # 99-230 – the effect of bacteriophage treatment as an intervention strategy to reduce the rapid dissemination of Salmonella typhimurium in experimentally infected pigs. National Pork Board. Ref Type: Report
Hsu, C. H., C. Y. Lo, J. K. Liu, and C. S. Lin. 2000. Control of the eel (Anguilla japonica) pathogens, Aeromonas hydrophila and Edwardsiella tardaEdwardsiella tarda, by bacteriophages. J. Fisheries Soc. Taiwan 27:21-31.
Norris, J. S., C. Westwater, and D. Schofield. 2000. Prokaryotic gene therapy to combat multidrug resistant bacterial infection [editorial]. Gene Ther. 7:723-725. review
Payne, R. J. H., D. Phil, and V. A. A. Jansen. 2000. Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals. Clin. Pharmacol. Ther. 68:225-230.
Pirisi, A. 2000. Phage therapy—advantages over antibiotics? Lancet 356:1418. review
Tai-wu, L., J. Xiang, and R. Liu. 2000. Studies on phage control of pustule disease in abalone Haliotis discus hannai. J. Shelfish Res. 19:535.
Travis, J. 2000. Viruses that slay bacteria draw new interest. Science News 157(June 3), 358-???. review
Wakefield, J. 2000. The return of the phage. Smithsonian 31(7):43-???. review
Weber-Dabrowska, B., M. Mulczyk, and A. Górski. 2000. Bacteriophage therapy of bacterial infections: An update of our institute's experience. Arch. Immunol. Ther. Exp. 48:547-551.
Weber-Dabrowska, B., M. Zimecki, and M. Mulczyk. 2000. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Arch. Immunol. Ther. Exp. 48:31-37.
??? 1999. Isolation and characterization of therapeutic phages specific for Serratia marcescens. Proceedings of the Georgian Academy of Sciences, Biology Series 25:14.
Carlton, R. M. 1999. Phage therapy: past history and future prospects. Arch. Immunol. Ther. Exp. 47:267-274. review
Kudva, I. T., S. Jelacic, P. I. Tarr, P. Youderian, and C. J. Hovde. 1999. Biocontrol of Escherichia coli O157 with O157-specific bacteriophages. Appl. Environ. Microbiol. 65:3767-3773.
Lorch, A. 1999. Bacteriophages: an alternative to antibiotics? Biotechnol. Dev. Mon. 39:14-17. review
Markoishvili, N., N. Djavakhishvili, M. Goderdzishvili, A. Meipariani, Z. Chavchanidze, G. Tsitlanadze, and R. Katsarava. 1999. PhageBioDerm – new prospects for treatment of wounds and trophic ulcers. Exp. Clin. Med. 2:83-84.
Nakai, T., R. Sugimoto, K.-H. Park, S. Matsuoka, K. Mori, T. Nishioka, and K. Maruyama. 1999. Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail. Dis. Aquat. Org. 37:33-41.
Ramesh, V., J. A. Fralick, and R. D. Rolfe. 1999. Prevention of Clostridium difficile-induced ileocecitis with bacteriophage. Anaerobe 5:69-78.
Rdamesh, V., J. A. Fralick, and R. D. Rolfe. 1999. Bacteriophage therapy of Clostridium difficile-associated intestinal disease in a hamster model. Miroecol. Anarobes[sic?] 5:69-???
Schnabel, E. L., W. G. D. Fernando, M. P. Meyer, and A. I. Jones. 1999. Bacteriophage of Erwinia amylovora and their potential for biocontrol, p. 649-653. In: M. T. Mornol and H. Saygili (eds.), Proceedings of the 8th International Workshop on Fire Blight. ISHS, Leuven, Belgium.
Stroj, L., B. Weber-Dabrowska, K. Partyka, M. Mulczyk, and M. Wojcik. 1999. [Successful treatment with bacteriophage in purulent cerebrospinal meningitis in a newborn]. Skuteczne zastosowanie bakteriofagoterapii w ropnym zapaleniu opon mozgowo-rdzeniowych u noworodka. Neurol. Neurochir. Pol. 33:693-698.
Akimkin, V. G., V. M. Bondarenko, N. N. Voroshilova, O. S. Darbeeva, and F. A. Baiguzina. 1998. [Practical use of adapted Salmonella bacteriophage for the treatment and prevention of nosocomial infections] Ispol'zovanie adaptirovannogo sal'monelleznogo bakteriofaga v praktike lecheniia i profilaktiki nozokomial'nogo sal'monelleza. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii 6:85-86.
Alisky, J., K. Iczkowski, A. Rapoport, and N. Troitsky. 1998. Bacteriophages show promise as antimicrobial agents. J. Infect. 36:5-15. review
Barrow, P., M. Lovell, and A. jr. Berchieri. 1998. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin. Diag. Lab. Immunol. 5:294-298.
Holzman, D. 1998. Reassessment of medicinal phage……. ASM News 64:620-622. review
Holzman, D. 1998. …Spurs companies to study therapeutic uses. ASM News 64:622-623. review
Holzman, D. 1998. Phage as antibacterial tool. Genet. Eng. News 18:1-48. review
Krylov, V. 1998. [Application of phage preparations for urologic diseases]. Medical Files.
Soothill, J. S. 1998. Phage therapy. J. Pharm. Pharmacol. 50:36. review
Barrow, P. A. and J. S. Soothill. 1997. Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol. 5:268-271. review
Hibma, A. M., S. A. Jassim, and M. W. Griffiths. 1997. Infection and removal of L-forms of Listeria monocytogenes with bred bacteriophage. Int. J. Food Microbiol. 34:197-207.
Kozminska, J., B. Weber-Dabrowska, and M. Mulczyk. 1997. [The study on biology of bacteriophages and their usage in the treatment of bacterial diseases and on the influence of different bacteriophages on cytokine production by leukocytes in human peripheral blood]. Otolaryngologia Polska 51 Suppl 25:195-198.
Mole, R., D. Meredith, and D. G. Adams. 1997. Growth and phage resistance of Anabaena sp. strain PCC 7120 in the presence of cyanophage AN-15. J. Appl. Phycol. 9:339-345.
??? 1996. Production of new treatment-prophylactic bacteriophage preparations active to Serratia marcescens and Enterobacter aerogenes, p. 68-71. In: Top. Quest. Microbiol. Virol.
Lederberg, J. 1996. Smaller fleas ... ad infinitum: therapeutic bacteriophage redux. Proc. Natl. Acad. Sci. USA 93:3167-3168. review
Levin, B. R. and J. J. Bull. 1996. Phage therapy revisited: the population biology of a bacterial infection and its treatment with bacteriophage and antibiotics. Am. Nat. 147:881-898. review
Long, P. F. and G. E. Amphlett. 1996. A super lytic actinophage system as a pre-treatment in the isolation of non-streptomycete actinomycetes from soil. Lett. Appl. Microbiol. 22:62-65.
Men'Shikov, D. D., G. Y. Yanisker, N. Y. Orlova, and E. D. Men'Shikova. 1996. [Use of bacteriophages as selective factors in bacteriological diagnosis of mixed infections] [Russian]. Klinicheskaya Laboratornaya Diagnostika 0(2).
Merril, C. R., B. Biswas, R. Carlton, N. C. Jensen, G. J. Creed, S. Zullo, and S. Adhya. 1996. bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. USA 93:3188-3192.
Mosa, A. A., N. Y. ABD El-Ghafar, and B. A. Othman. 1996. Bacteriophages of Pseudomonas solanacearum and their potential for biological control of potato bacterial wilt. Zagazig J. Agric. Res. 23:1053-1063.
Smit, E., A. C. Wolters, H. Lee, J. T. Trevors, and J. D. van Elsas. 1996. Interactions between a genetically marked Pseudomonas fluorescens strain and bacteriophage PHI-R2f in soil: Effects of nutrients, alginate encapsulation, and the wheat rhizosphere. Microb. Ecol. 31:125-140.
Gabisonia, T. G. and others??? 1995. Phagotherapy of nosocomial strains of P. aeruginosa, belonging to the o-groups. Georg. Med. News. N.15:19-21.
Goto, Y. and M. Kitayama. 1995. A study on cyanophages inhibiting the growth of algae producing musty odor. Water Supply 13:263-266.
Munsch, P. and J. M. Olivier. 1995. Biocontrol of bacterial blotch of the cultivated mushroom with lytic phages: some practical considerations, p. 595-602. In: T. J. Elliott (ed.), Science and Cultivation of Edible Fungi, Vol. II: Proceedings of the 14th International Congress.
Patten, K. M., D. I. Kurtböke, and D. R. Lindsay. 1995. Isolation of Dermatophilus congolensis phage from the 'lumpy wool' of sheep in Western Australia. Lett. Appl. Microbiol. 20:199-203.
Perepanova, T. S., O. S. Darbeeva, G. A. Kotliarova, E. M. Kondrat'eva, L. M. Maiskaia, V. F. Malysheva, F. A. Baiguzina, and N. V. Grishkova. 1995. [The efficacy of bacteriophage preparations in treating inflammatory urologic diseases] [Russian]. Urologiia i Nefrologiia14-17.
Boratynska, M., Z. Szewczyk, and B. Weber-Dabrowska. 1994. [The clinical evaluation of bacteriophage treatment of urinary infections] (in Polish). Post. Med. Klin. Dosw. 3:7-11.
Dixon, B. 1994. Bacteriophage: A smart alternative to antibiotics?, p. 190-192. In: The Power Unseen. W.H.Freeman/Spektrum, Oxford, UK. review
Kwarcinski, W., B. Lazarkiewicz, B. Weber-Dabrowska, J. Rudnicki, K. Kaminski, and M. Sciebura. 1994. [Bacteriophage therapy in the treatment of recurrent subphrenic and subhepatic abscess with jejunal fistula after stomach resection] [Polish]. Polski Tygodnik Lekarski 49:535.
Soothill, J. S. 1994. Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. Burns 20:209-211.
Zaccardelli, M., A. Saccardi, E. Gambin, P. Minardi, U. Mazzucchi, M. Lemattre, S. Freigoun, K. Rudolph, and J. G. Swings. 1994. Xanthomonas campestris pv. pruni bacteriophages on peach trees and their potential use for biological control. Colloques de l'INRA 66???:875-878.
Ali, S. M., M. B. Saleh, and A. I. Merdan. 1993. Comparative inhibitory action of 4 standard bacteriophages on the larvicidal activity of certain mosquito pathogenic bacteria against Culex pipiens larvae. J. Egyp. Soc. Parasitol. 23:341-348.
Kurtböke, D. I., N. E. Murphy, and K. Sivasithamparam. 1993. Use of bacteriophage for the selective isolation of thermophilic actinomycetes from composted eucalyptus bark. Can. J. Microbiol. 39:46-51.
Pavlenishvili, I. and T. Tsertsvadze. 1993. Bacteriophagotherapy and enterosorbtion in treatment of sepsis of newborns caused by gram-negative bacteria. Pren. Neon. Infect. 11:104.
Roy, B., H.-W. Ackermann, S. Pandian, G. Picard, and J. Goulet. 1993. Biological inactivation of adhering Listeria monocytogenes by listeriaphages and a quaternary ammonium compound. Appl. Environ. Microbiol. 59:2914-2917.
Saccardi, A., E. Gambin, M. Zaccardelli, G. Barone, and U. Mazzucchi. 1993. Xanthomonas campestris pv. pruni control trials with phage treatments on peaches in the orchard. Phytopathologia Mediterranea 32:206-210.
Basit, H. A., J. S. Angle, S. Salem, and E. M. Gewaily. 1992. Phage coating of soybean seeds reduces nodulation by indigenous soil bradyrhizobia. Can. J. Microbiol. 38:1264-1269.
Bogovazova, G. G., N. N. Voroshilova, V. M. Bondarenko, G. A. Gorbatkova, E. V. Afanas'eva, T. B. Kazakova, V. D. Smirnov, A. G. Mamleeva, I. Glukharev, and E. I. Erastova. 1992. [Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages] [Russian]. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii (3):30-33.
Kurtböke, D. I., C. F. Chen, and S. T. Williams. 1992. Use of polyvalent phage for reduction of streptomycetes on soil . J. Appl. Bacteriol. 72:103-111.
Reynaud, A., L. Cloastre, J. Bernard, H. Laveran, H.-W. Ackermann, D. Licois, and B. Joly. 1992. Characteristics and diffusion in the rabbit of a phage for Escherichia coli 0103. Attempts to use this phage for therapy. Vet. Microbiol. 30:203-212.
Soothill, J. S. 1992. Treatment of experimental infections of mice with bacteriophages. J. Med. Microbiol. 37:258-262.
Zaccardelli, M., A. Saccardi, E. Gambin, and U. Mazzuchi. 1992. Xanthomonas campestris pv. pruni bacteriophages on peach trees and their potential use for biological control. Phytopathologia Mediterranea 31:133-140.
Berchieri, A. jr., M. A. Lovell, and P. A. Barrow. 1991. The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res. Microbiol. 142:541-549.
Bogovazova, G. G., N. N. Voroshilova, and V. M. Bondarenko. 1991. [The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection]. Zh. Mikrobiol. Epidemiol. Immunobiol. (4):5-8.
Hussein, M. E., A. Merdan, N. A. A. Razik, S. A. Morsi, and M. B. Saleh. 1991. The effects of certain phages of Bacillus spp. on the larvicidal potency of Bacillus thuringiensis and Bacillus sphaericus . J. Appl. Entomol. 112:176-180.
Monegue, R. L. and E. J. Phlips. 1991. The effect of cyanophages on the growth and survival of Lyugbya wollei, Anabaenaflos aquae, and Anabaena circinalis. J. Aquat. Plant. Manage. 29:88-93.
Munsch, P., J. L. Olivier, and G. Houdeau. 1991. Experimental control of bacterial blotch by bacteriophages, p. 389-396. In: M. J. Maher (ed.), Mushroom Science., vol. XIII Rotterdam, Netherlands.
Radetsky, P. 1991. The virus that eats bacteria, p. 74-88. In: The Invisible Invaders: The Story of the Emerging Age of Viruses. Little Brown & Company, Boston. review
Sakandelidze, V. M. 1991. The combined use of specific phages and antibiotics in different infectious allergoses. Vrach. Delo 3:60-63.
Zemskova, Z. S. and I. R. Dorozhkova. 1991. Pathomorphological evaluation of therapeutic effect of mycophages in tuberculosis. Probl. Tuberk. 11:63-66.
Abdul-Hassan, H. S., B. El-Tahan k Massoud, and R. Gomaa. 1990. Bacteriophage therapy of Pseudomonas burn wound sepsis. Ann. Med. Burn Club 3:262-264.
Araki, M. and M. Hosomi. 1990. Using bacteriophage for slime control in the paper mill. TAPPI J. 73:155-158.
DeBoer, D. J. 1990. Canine staphylococcal pyoderma-new knowledge and therapeutic advances. Vet. Med. Rpt. 2:1254-1266.
DeBoer, D. J., K. T. Schultz, C. B. Thomas, and K. A. Moriello. 1990. Clinical and immunological responses of dogs with recurrent pyoderma to injections of staphylococcus phage lysate. Adv. Vet. Dermatol. 1:335-346.
DeBoer, D. J., K. A. Moriello, C. B. Thomas, and K. T. Schultz. 1990. Evaluation of a commercial staphylococcal bacterin for management of idiopathic recurrent superficial pyoderma in dogs. Am. J. Vet. Res. 51:636-639.
DeBoer, D. J. 1990. Strategies for management of recurrent pyoderma in dogs. Vet. Clin. N. Am. Small. Anim. Prac. 20:1509-1524.
Greer, G. G. and B. D. Dilts. 1990. Inability of a bacteriophage pool to control beef spoilage. Int. J. Food Microbiol. 10:331-342.
Kaczkowski, H., B. Weber-Dabrowska, M. Dabrowski, Z. Zdrojweicz, and F. Cwioro. 1990. Use of bacteriophages and antibiotics for prevention of acute postoperative empyema in chronic suppurative lung diseases. Wiad. Lek. 43:136-141.
Chernomordick, A. B. 1989. [Bacteriophages and their therapeutic-prophylactic use]. Med. Sestra. 6:44-47. review
Kochetkova, V. A., A. S. Mamontov, R. L. Moskovtseva, E. I. Erastova, E. I. Trofimov, M. I. Popov, and S. K. Dzhubalieva. 1989. [Phagotherapy of postoperative suppurative-inflammatory complications in patients with neoplasms] [Russian]. Sov Med23-26.
Sakaguchi, I., K. Shinshima, K. Kawaratani, and O. Sugai. 1989. Control of microbiofouling using bacteriophage 2. detection of phages and fundamental study of their lytic effect on fouling bacteria. Denryoku Chuo Kenkyusho Hokoku 1-32.
Greer, G. G. 1988. Effects of phage concentration, bacterial density, and temperature on phage control of beef spoilage. J. Food. Sci. 53:1226-1227.
Guillaumes, J., G. Houdeau, R. Germain, and J. M. Olivier. 1988. Improvement of the biocontrol of Pseudomonas tolaasii using bacteriophages associated with an antagonistic bacterium. Bull. OEPP 18:77-82.
Lenski, R. E. 1988. Dynamics of interactions between bacteria and virulent bacteriophage. Adv. Microbial. Ecol. 10:1-44. review
Martin, E. L. and R. Benson. 1988. Phages of cyanobacteria, p. 607-645. In: R. Calendar (ed.), The Bacteriophages, vol. 2. Plenum Press, New York. review
Soothill, J. S., J. C. Lawrence, and G. A. J. Ayliffe. 1988. The efficacy of phages in the prevention of the destruction of pig skin in vitro by Pseudomonas aeruginosa. Med. Sci. Res. 16:1287-1288.
Ackermann, H.-W. and M. S. DuBow. 1987. Practical applications of bacteriophages, p. 143-172. In: H.-W. Ackermann and M. S. DuBow (eds.), Viruses of Prokaryotes. Volume I. General properties of bacteriophages. CRC Press, Boca Raton, FL. review
Angel, M. F., S. S. Ramasastry, E. K. Manders, D. Ganfield, and J. W. Futrell. 1987. Beneficial effect of Staphage lysate in the treatment of chronic recurring hidradenitis suppurativa. Surgical forum 38:111.
Cislo, M., M. Dabrowski, B. Weber-Dabrowska, and A. Woyton. 1987. Bacteriophage treatment of suppurative skin infections. Arch. Immunol. Ther. Exp. 35:175-183.
Dixon, B. 1987. Bacteriophage therapy. Brit. Med. J. (Clin. Res. Ed. ) 294:1168. review
Kucharewicz-Krukowska, A. and S. Slopek. 1987. Immunogenic effect of bacteriophage in patients subjected to phage therapy. Arch. Immunol. Ther. Exp. 35:553-561.
Meitert, E., M. Petrovici, E. Sima, G. Costache, and C. Savulian. 1987. Investigation on the therapeutical efficiency of some adapted bacteriophages in experimental infection with Pseudomonas aeruginosa. Arch. Roum. Pathol. Exp. Microbiol. 46:17-26.
Slopek, S., B. Weber-Dabrowska, M. Dabrowski, and A. Kucharewicz-Krukowska. 1987. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch. Immunol. Ther. Exp. 35:569-583.
Smith, H. W., M. B. Huggins, and K. M. Shaw. 1987. Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. J. Gen. Microbiol. 133:1127-1135.
Smith, H. W., M. B. Huggins, and K. M. Shaw. 1987. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J. Gen. Microbiol. 133:1111-1126.
Weber-Dabrowska, B., M. Dabrowski, and S. Slopek. 1987. Studies on bacteriophage penetration in patients subjected to phage therapy. Arch. Immunol. Ther. Exp. 35:563-568.
Wu, J. L. and W. J. Chao. 1987. The epizootic of milkfish vibriosis and its biological control by bacteriophage AS10, In: K. S. Kou, J. L. Wu, Y. L. Hsu, S. N. Chen, M. C. Tung, I. C. Liao, and H. Y. Chung (eds.), The Memoir of Virology and Pharmacology in Fish Disease. 3., vol. 12? Taipei.
Greer, G. G. 1986. Homologous bacteriophage control of Pseudomonas growth and beef spoilage. J. Food Prot. 49:104-109.
Kilnadze, G. P., M. M. Gadua, E. V. Tsereteli, L. S. Mchedlidze, and T. V. Birkadze. 1986. Efficiency of preventive treatment by phage preparations of children's hospital salmonellosis, p. 41-44. In: G. P. Kiknadze (ed.), Intestinal Infections. Sovetskaya Meditsina, Tbilisis, Georgia.
Lenski, R. E. and B. R. Levin. 1985. Constraints on the coevolution of bacteria and virulent phage: A model, some experiments, and predictions for natural communities. Am. Nat. 125:585-602. [Local Link] review
Levin, B. R. and R. E. Lenski. 1985. Bacteria and phage: a model system for the study of the ecology and co-evolution of hosts and parasites, p. 227-242. In: D. Rollinson and R. M. Anderson (eds.), Ecology and Genetics of Host-Parasite Interactions. Academic Press, London. [Local Link] review
Slopek, S., A. Kucharewicz-Krukowska, B. Weber-Dabrowska, and M. Dabrowski. 1985. Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of results obtained in 370 cases. Arch. Immunol. Ther. Exp. 33:219-240.
Slopek, S., A. Kucharewicz-Krukowska, B. Weber-Dabrowska, and M. Dabrowski. 1985. Results of bacteriophage treatment of suppurative bacterial infections. V. Evaluation of the results obtained in children. Arch. Immunol. Ther. Exp. 33:241-259.
Slopek, S., A. Kucharewicz-Krukowska, B. Weber-Dabrowska, and M. Dabrowski. 1985. Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections. Arch. Immunol. Ther. Exp. 33:261-273.
Timoshchuk, I. I., E. I. Natsiashvili, T. G. Chanishvili, and G. D. Meladze. 1985. [Experience with bacteriophage therapy in nonspecific suppurative lung diseases] [Russian]. Grudnaia Khirurgiia11-13.
Anpilov, L. I. and A. A. Prokudin. 1984. [Preventive effectiveness of dried polyvalent Shigella bacteriophage in organized collective farms]. Voenno-Med. Zh. 5:39-40.
Graves, D. A. and R. W. Beck. 1984. The use of a lytic bacteriophage to remove Rhizobium trifolii from protoplast culture of Trifolium repens. Plant Sci. Lett. 34:385-389.
Kamimura, K. and M. Araki. 1984. Control of microbiofouling formed on the heat exchanger by bacteriophage, p. 40-46. In: Proceedings of the Pacific Congress on Marine Technology (Honolulu, Hawaii).
Martynova, V. A., G. L. Ermakova, T. V. Golosova, and E. M. Abakumov. 1984. [Local immunity of the upper respiratory tract in patients with acute leukemia]. Voprosy Onkologii 30:59-63.
Samsygina, G. A. and E. G. Boni. 1984. [Bacteriophages and phage therapy in pediatric practice] [Russian]. Pediatriia 67-70. review
Slopek, S., I. Durlakowa, B. Weber-Dabrowska, M. Dabrowski, and A. Kucharewicz-Krukowska. 1984. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases. Arch. Immunol. Ther. Exp. 32:317-335.
Anonymous. 1983. Phage therapy. Lancet 2(8362):1287-1288. review
Desjardins, P. R. 1983. Cyanophage: History and likelihood as a control, p. 242-248. In: Lake Restoration, Protection, and Management. Environmental Protection Agency, Washington, D.C. review
Desjardins, P. R. and G. B. Olson. 1983. Viral Control of Nuisance Cyanobacteria (Blue-Green Algae). II. Cyanophage Strains, Stability on Phages and Hosts, and Effects of Environmental Factors on Phage-Host Interactions. California Water Resource Center, University of California, Davis, CA. review
Shaw, D. R., A. T. Maurelli, J. D. Goguen, S. C. Straley, and R. Curtiss, III. 1983. Use of UV-irradiated bacteriophage T6 to kill extracellular bacteria in tissue culture infectivity assays. J. Immunol. Meth. 56:75-83.
Slopek, S., I. Durlakova, B. Weber-Dabrowska, A. Kucharewicz-Krukowska, M. Dabrowski, and R. Bisikiewicz. 1983. Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results. Arch. Immunol. Ther. Exp. 31:267-291.
Slopek, S., I. Durlakova, B. Weber-Dabrowska, A. Kucharewicz-Krukowska, M. Dabrowski, and R. Bisikiewicz. 1983. Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evalulation of the results. Arch. Immunol. Ther. Exp. 31:293-327.
Smith, H. W. and M. B. Huggins. 1983. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J. Gen. Microbiol. 129:2659-2675.
Greer, G. G. 1982. Psychotrophic bacteriophages for beef spoilage pseudomonads. J. Food Prot. 45:1318-1325.
Harrap, K. A. 1982. Assessment of the human and ecological hazards of microbial insecticides. Parasitology 84:269-296. review
Martin, E. L. 1982. The biological regulation of bloom-causing blue-green algae: A feasible alternative. Project Completion Report. Nebraska Water Resources Center, Lincoln, Nebraska.
Meladze, G. D., M. G. Mebuke, N. S. Chkhetia, N. I. Kiknadze, G. G. Koguashvili, I. I. Timoshuk, N. G. Larionova, and G. K. Vasadze. 1982. [Efficacy of staphylococcal bacteriophage in treatment of purulent diseases of lungs and pleura]. Grudnaia Khirurgiia 1:53-56.
Smith, H. W. and M. B. Huggins. 1982. Successful treatment of experimental Escherichia coli infections in mice using phage: Its general superiority over antibiotics. J. Gen. Microbiol. 128:307-318.
Desjardins, P. R. 1981. Cyanophages—are they potential biological control agents of nuisance blue-green algae?, p. 198-229. In: Proceedings of Workshop on Algal Management and Control. E-81-7 ed. U.S. Army Engineer Waterways Experiment Station, Pacific Grove, California. review
Filho, A. B. and H. Kimati. 1981. [Studies on a bacteriophage isolated from Xanthomonas campestris II. Its use in the control of X. campestris and X. campestris vesicatoria] Estudos sobre um bacteriophago isolado de Xanthomonas campestris II. Seu emprego no controle de X. campestris e X. campestris vesicatoria. Summa Phytopathol. 7:35-43.
Kress, D. W., W. P. Graham, T. S. Davis, and S. H. Miller. 1981. A preliminary report on the use of Staphage Iysate for treatment of hidradenitis suppurativa. Annals Of Plastic Surgery 6:393-395.
Peremitina, L. D., E. A. Berillo, and A. G. Khvoles. 1981. Experience in the therapeutic use of bacteriophage preparations in suppurative surgical infections. Zh. Mikrobiol. Epidemiol. Immunobiol. 9:109-110.
Rola-Pleszczynski, M., S. Massé, P. Sirois, I. Lemaire, and R. Bégin. 1981. Early effects of low-doses exposure to asbestos on local cellular immune responses in the lung. J. Immunol. 127:2535-2538.
Sula, L., J. Sulova, and M. Stolcpartova. 1981. Therapy of experimental tuberculosis in guinea pigs with mycobacterial phages DS-6A, GR-21 T, My-327. Czech Med 4:209-214.
Tolkachera, T. Y., E. M. Abakumova, V. A. Martynova, and T. V. Golosova. 1981. [Correction of intestinal dysbacteriosis with biological preparations in acute leukemia] Korrektsiia disbakterioza kishechnika biologicheskimi preparatami u bol'nykh ostrymi leiozami. Problemy Germatologii i Perelivaniia Krovi 26:29-33.
Wu, J. L., H. M. Lin, L. Jan, Y. L. Hsu, and L. H. Chang. 1981. Biological control of fish bacterial pathogen, Aeromonas hydrophila by bacteriophage AH 1. Fish Pathol. 15:271-276.
Corbel, M. J. and J. A. Morris. 1980. Investigation of the effect of Brucella-phage on the course of experimental infection with Brucella abortus. Br. Vet. J. 136:278-289.
Ioseliani, G. D., G. D. Meladze, N. S. Chkhetiia, M. G. Mebuke, and N. I. Kiknadze. 1980. [Use of bacteriophages and antibiotics for prevention of acute postoperative empyema in chronic suppurative lung diseases]. Grudnaia Khirurgiia 6:63-67.
Lang, G., P. Kehr, H. Mathevon, J. M. Clavert, P. Sejourne, and J. Pointu. 1979. [Bacteriophage therapy of septic complications of orthopaedic surgery]. Rev Chir Orthop. Reparatrice Appar. Mot. 65:33-37.
Nicolle, P. 1979. [About of the therapy with the bacteriophages]. Bull. Acad. Med. Paris 163:58-60. review
Vieu, J. F., F. Guillermet, R. Minck, and P. Nicolle. 1979. [New trends in therapeutic use of bacteriophages]. Bull. Acad. Med. Paris 163:61-66. review
Desjardins, P. R., M. B. Barkley, S. A. Swiecki, and S. N. West. 1978. Viral Control of Blue-Green Algae. California Water Resource Center, University of California. review
Litvinova, A. M., V. M. Chtetsova, and I. G. Kavtreva. 1978. Evaluation of efficacy of the use of E. coli-Proteus bacteriophage in intestinal dysbacteriosis in premature infants. Vopr. Okhr. Materin. Det. 9:42-44.
Martin, E. L., J. E. Leach, and K. J. Kuo. 1978. The biological regulation of bloom-causing blue-green algae, p. 62-67. In: M. W. Louitit and J. A. R. Miles (eds.), Microbial Ecology. Springer-Verlag, Berlin. review
Riche, P. H., P. Vic, C. Humeau, H. Vanneraeau, B. Vlahovitch, and P. Sentein. 1978. Decontamination of bacterial infection of monolayer cultures with a specific bacteriophage. in vitro 14:935-???
Zhukov-Verezhnikov, N. N., L. D. Peremitina, E. A. Berillo, V. P. Komissarov, and V. M. Bardymov. 1978. Therapeutic effect of bacteriophage preparations in the complex treatment of suppurative surgical diseases. Sov. Med.64-66.
Pipiia, V. I., G. P. Eteriia, T. P. Gotua, V. I. Volobuev, and V. S. Katsarava. 1976. [Experience with treating complicated forms of abscessing pneumonia in children]. [Russian]. Vestnik Khirurgii Imeni i - i - Grekova 117:64-68.
Stewart, W. D. P. and M. J. Daft. 1976. Algal lysing agents of freshwater habitats, p. 63-90. In: F. A. Skinner and J. G. Carr (eds.), Microbiology in Agriculture, Fisheries and Food, Symposium Series #4. Academic Press, New York.
Vidaver, A. K. 1976. Prospects for control of phytopathogenic bacteria by bacteriophage and bacteriocins. Ann. Rev. Phytopathol. 14:451-465. review
Cannon, R. 1975. Field and ecological studies on blue-green algal viruses, p. 112-117. In: P. L. Brezonic and J. L. Fox (eds.), The Proceedings of a Symposium on Water Quality Management through Biological Control. Department of Engineering Sciences, University of Florida.
Koz'min-Sokolov, B. N. 1975. [Effect of mycobacteriophages on the course of experimental tuberculosis in albino mice]. Problemy tuberkuleza75-79. review
Wilson, G. S. and A. A. Miles. 1975. Topley and Wilson's Principles of Bacteriology and Immunity. Edward Arnold, London.
Mulczyk, M. and S. Slopek. 1974. Use of a new phage preparation in prophylaxis and treatment of shigellosis. Acta Microbiol. Acad. Sci. Hungary 21:115-119.
Sakandelidze, V. M. and A. N. Meipariani. 1974. Use of combined phages in suppurative-inflammatory urologic diseases. Zh. Mikrobiol. Epidemiol. Immunobiol. 6:135-136.
Vartapetov, A. I. 1974. [Materials on the study of bacteriophage therapy of deep forms of staphyloderma]. [Russian]. Vestnik Dermatologii i Venerologii8-11.
Ellis, D. E., P. A. Whitman, and R. T. Marshall. 1973. Effects of homologous bacteriophage on Pseudomonas growth of Pseudomonas fragi in milk. Appl. Microbiol. 25:24-25.
Pavlova, L. I., A. A. Sumarokov, P. Solodovnikov Iu, and N. M. Nikitiuk. 1973. Use of dysentery bacteriophage as a means of preventing dysentery. Zh. Mikrobiol. Epidemiol. Immunobiol. 50:27-32.
Safferman, R. S. 1973. Phycoviruses, p. 214-237. In: N. G. Carr and B. A. Whitton (eds.), The Biology of Blue-Green Algae. University of California Press, Berkeley.
Brown, R. M., Jr. 1972. Algal Viruses. Adv. Virus Res. 17:243-277. [Local Link] review
Boyd, R. J., A. C. Hildebrant, and O. N. Allen. 1971. Retardation of crown gall enlargement after bacteriophage treatment. Plant Dis. Rep. 55:145-148.
Shilo, M. 1971. Biological agents which cause lysis of blue-green algae. Verh. Internat. Verein Limnol. 19:206-213. [Local Link] review
Solodovnikov Iu, P., L. I. Pavlova, N. A. Gamova, B. Nogteva Iu, and S. Sotemskii Iu. 1971. Preventive use of dry polyvalent dysentery bacteriophage in preschool institutions. II. Principles of present-day tactics and application schedule of bacteriophage. Zh. Mikrobiol. Epidemiol. Immunobiol. 48:123-127.
Monsur, K. A., M. A. Rahman, E. Huq, M. N. Islam, R. S. Northrup, and N. Hirschhorn. 1970. Effect of massive doses of bacteriophage on excretion of vibrios, duration of diarrhoea and output of stools in acute cases of cholera. Bull. World Health Org. 42:723-732.
Orlova, Z. N. and N. A. Gamova. 1970. Use of tablet-form polyvalent bacteriophage with acid resistant coating in the treatment of dysentery in children. Vopr. Okhr. Materin. Det. 15:25-29.
Proskurov, V. A. 1970. Treatment of staphylococcal eye infections. Vestn. Ophthalmol. 6:82-83.
Proskurov, V. A. 1970. Use of staphylococcal bacteriophage for therapeutic and preventive purposes. Zh. Mikrobiol. Epidemiol. Immunobiol. 2:104-107.
Shera, G. 1970. Phage treatment for severe burns. Br. Med. 1:568-569. review
Zhukov-Verezhnikov, N. N., L. D. Peremitina, E. A. Berillo, V. P. Komissarov, V. M. Bardymov, A. G. Khvoles, and L. B. Ugryumov. 1970. A study of the therapeutic effect of bacteriophage agents in a complex treatment of suppurative surgical diseases. Sov. Med. 12:64-66.
Civerolo, E. L. and H. L. Kiel. 1969. Inhibition of bacterial spot of peach foliage by Xanthomonas pruni bacteriophage. Phytopathology 59:1966-1967.
Peelen, R. 1969. Possibilities to prevent blue-green algal growth in the Delta region of the Netherlands. Verh. Internat. Verein Limnol. 17:763-766. [Local Link] review
Peitzman, S. J. 1969. Felix d'Herelle and bacteriophage therapy. Trans. Stud. Coll. Physicians Phila. 37:115-123. review
Pillich, J., F. Vymola, and J. Buda. 1969. [Assumptions for successful therapy using staphylococcal phage lysates]. [German]. Zentralblatt Fur Bakteriologie, Parasitenkunde, Infektionskrankheiten Und Hygiene - 1 - Abt - Medizinisch-Hygienische Bakteriologie, Virusforschung Und Parasitologie - Originale 210:377-381.
Shilo, M. 1969. New approaches to the control of harmful brackish and fresh water algae of economic importance. Biotech. Bioeng. Symp. 1:177-184. [Local Link] review
Zilisteanu, C., L. Mintzer-Morgenstern, H. Ionesco, and T. Ionesco-Dorohoi. 1969. [Further data on the association of bacteriophage with antibiotic therapy for the purpose of sterilizing carriers of dysentery bacilli]. [French]. Archives Roumaines de Pathologie Experimentales et de Microbiologie 28:1073-1080.
Babalova, E. G., K. T. Katsitadze, L. A. Sakvarelidze, N. S. Imnaishvili, T. G. Sharashidze, V. A. Badashvili, G. P. Kiknadze, A. N. Meipariani, N. D. Gendzekhadze, E. V. Machavariani, K. L. Gogoberidze, E. I. Gozalov, and N. G. Dekanosidze. 1968. Prevenative value of dried dysentery bacteriophage. Zh. Mikrobiol. Epidemiol. Immunobiol. 2:143-145.
Buda, J., K. Suk, F. Vymola, and J. Pillich. 1968. Treatment of recurrent inflammation of Bartholin's gland with staphylococcal lysate. Cesk. Gynekol. 33:669-672.
Etana, P. and M. Shilo. 1968. Spread of viruses attacking blue-green algae in freshwater ponds and their interaction with Plectonema boryanum . Bamidgeh 20:77-88.
Ha, T.-Y. 1968. Studies on protection of Klebsiella pneumoniae-infected mouse with phage. J. Korean Mod. Med. 8:395-???
Matusis, Z. E., V. D. Mel'nikov, and A. Gerasimov. 1967. [Effectiveness of phage therapy in experimental Proteus infection]. Zh. Mikrobiol. Epidemiol. Immunobiol. 44:100-103.
Stonier, T., J. McSharry, and T. Speitel. 1967. Agrobacterium tumefaciens Conn IV. Bacteriophage PB2 and its inhibitory effect on tumor induction. J. Virol. 1:268-273.
Wittig, H. J., J. F. Raffetto, and R. Bason. 1966. Bacteriophage therapy in infective childhood asthma. J. Am. Med. Assoc. 196:435.
Bryant, R. E. and et al. 1965. Treatment of recurrent furunculosis with staphylococcal bacteriophage-lysed vaccine. J. Am. Med. Assoc. 194:11-14.
Zilisteanu, C., A. Filotti, L. Mintzer-Morgenstern, and G. Ghyka. 1965. [Association of bacteriophage with antibiotic therapy for the sterilization of carriers of dysentery bacilli]. [French]. Archives Roumaines de Pathologie Experimentales et de Microbiologie 24:1021-1028.
Okabe, N. and M. Goto . 1963. Bacteriophages of plant pathogens. Ann. Rev. Phytopathol. 1:397-418. review
Salmon, G. and M. Symonds. 1963. Staphage lysate therapy in chronic staphylococcal infections. J. Med. Soc. 60:188-193.
Sayamov, R. M. 1963. Treatment and prophylaxis of cholera with bacteriophage. Bull. W. H. O. 28:361-???
Stent, G. S. 1963. Molecular Biology of Bacterial Viruses. WH Freeman and Co., San Francisco, CA. [Local Link] review
Witoszka, M. and B. Strumillo. 1963. [Bacteriophage therapy of infected surgical wounds.]. Pol. Tyg. Lek. 18:430-432.
Claeys, R. 1962. [Study on a product with antibiotic action: antibiophagin.]. Acta Otorhinolaryngol. Belg. 16:32-38.
Return to Home or see Phage Terms/Glossary.
Contact web master.
